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Abstract 
Little is known about the impact of dietary fiber (DF) on children.  Current 
recommendations are based on extrapolations from adult studies.  Research is needed to provide 
science based evidence to determine how DF impacts the gut of children.  Two studies were 
conducted to investigate the interactions of DF in the child large intestine.  In the first study, the 
dose response of DF on breath hydrogen, methane, and total hydrogen content was investigated 
relative to Institute of Medicine (IOM) recommended intakes in free-living preschool children.  
Only four of the 18 participants were able to comply with the treatment protocol.  Although, no 
significant differences were noted in breath measures of fermentation across fiber consumption 
levels, there was a numerical pattern for increasing levels of DF to evolved increased gas 
production in the four compliers.  In free-living individuals measures of acute fiber fermentation 
through breath was not sensitive enough over 6 hours to distinguish a difference in fermentative 
rate.  Children, parents, and child care centers found this approach apparently acceptable.  In 
study two, the impact of DF (10 g) fed over three weeks in children and their parents on 
metabolic markers of fermentation were evaluated. The body was able to adapt to 10 g/day DF 
consumption as bloating (p <  0.05) and flatulence (p = 0.06) decreased each week of the study.  
Fecal propionic acid was significantly increased over three weeks of DF supplementation.  There 
was also an interaction (p=0.05) between time and age for butyric acid.  Dietary fiber 
supplementation (10 g/day) over three weeks via a commercially available extruded cereal was 
well-tolerated by the participants, with no disturbances in bowel habit in children or adults.  
Alternatively, there were no improved bowel habit measures with increased DF consumption.  
This study provides evidence that this tolerable dose of DF supplementation over three weeks 
had similar impacts in free-living children and adults.  However, the presence of increased 
butyric acid only in children may be reflective of different production or absorptive capacities 
between children and adults.  Although not presented here, the bacterial ecological analysis may 
shed further insight into the interactions occurring in the large intestine.  These are the first 
studies to my knowledge to have investigated these outcomes in young children.  In addition to 
the gut health outcomes, this research provided a framework into the apparent feasibility of 
studying children in a gentle, non-invasive, and cost-effective manner. 
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Abstract 
Little is known about the impact of dietary fiber (DF) on children.  Current 
recommendations are based on extrapolations from adult studies.  Research is needed to provide 
science based evidence to determine how DF impacts the gut of children.  Two studies were 
conducted to investigate the interactions of DF in the child large intestine.  In the first study, the 
dose response of DF on breath hydrogen, methane, and total hydrogen content was investigated 
relative to Institute of Medicine (IOM) recommended intakes in free-living preschool children.  
Only four of the 18 participants were able to comply with the treatment protocol.  Although, no 
significant differences were noted in breath measures of fermentation across fiber consumption 
levels, there was a numerical pattern for increasing levels of DF to evolved increased gas 
production in the four compliers.  In free-living individuals measures of acute fiber fermentation 
through breath was not sensitive enough over 6 hours to distinguish a difference in fermentative 
rate.  Children, parents, and child care centers found this approach apparently acceptable.  In 
study two, the impact of DF (10 g) fed over three weeks in children and their parents on 
metabolic markers of fermentation were evaluated. The body was able to adapt to 10 g/day DF 
consumption as bloating (p <  0.05) and flatulence (p = 0.06) decreased each week of the study.  
Fecal propionic acid was significantly increased over three weeks of DF supplementation.  There 
was also an interaction (p=0.05) between time and age for butyric acid.  Dietary fiber 
supplementation (10 g/day) over three weeks via a commercially available extruded cereal was 
well-tolerated by the participants, with no disturbances in bowel habit in children or adults.  
Alternatively, there were no improved bowel habit measures with increased DF consumption.  
This study provides evidence that this tolerable dose of DF supplementation over three weeks 
had similar impacts in free-living children and adults.  However, the presence of increased 
butyric acid only in children may be reflective of different production or absorptive capacities 
between children and adults.  Although not presented here, the bacterial ecological analysis may 
shed further insight into the interactions occurring in the large intestine.  These are the first 
studies to my knowledge to have investigated these outcomes in young children.  In addition to 
the gut health outcomes, this research provided a framework into the apparent feasibility of 
studying children in a gentle, non-invasive, and cost-effective manner. 
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Preface 
This manuscript was written according to the style guidelines of the intended site of 
journal submission.  Journal selection was chosen based on content of each paper and the 
intended audience, ensured to meet journal coverage criteria.  Chapter 1 is a general 
introduction, including the overall research objectives and statement of hypotheses.  This will be 
referenced according to the general format of APA.  Chapter 2 is a review of literature 
pertaining to dietary fiber definition, relationship to children, and metabolic interactions 
regarding the large intestine.  Chapter 3 is an investigation into the effects and feasibility of 
dietary fiber intake by children on fermentation in the large intestine, via a non-invasive and 
gentle methodology.  Chapter 4 is a continuation on Chapter 3, investigating the effects of 
dietary fiber on fundamental metabolic mechanisms of fermentation in free-living children and 
their parents, using non-invasive and gentle methodology, with regard to each individual’s DF 
recommendations.  Chapter 5 is a further continuation of Chapter 4 investigating the 
relationship of the colonic microflora with respect to age, dietary fiber consumption, and non-
invasive, gentle metabolic markers of fermentation in free-living individuals.  Chapter 6 draws 
general conclusions regarding dietary fiber intake in children as assessed by these investigations 
and where future research should focus resources. 
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Chapter 1 - General Introduction 
Dietary fiber (DF) is a complex molecule that has been described as “unrealistic” (Van 
Soest, 1994) to define, at least with current methodology and approaches. Fiber has been defined 
(not measured) traditionally by its presence in plant tissues, which are then consumed (Burkitt, 
1974; Hipsley, 1953; Trowell & Burkitt, 1986).  More recently, the role of fiber has diverged 
(Lattimer & Haub, 2010) into both a physiological and a chemical component.  This is reflected 
by the Food and Nutrition Board (FNB) 2002 definition of fiber.  The first component DF, is 
defined as: “Dietary fiber which consists of isolated, non-digestible carbohydrates and lignin that 
are intrinsic and intact in plants.”  The second component is composed of functional fiber (FF), 
which has been defined as: “Functional fiber consists of isolated, non-digestible carbohydrates 
that have beneficial physiological effects in humans.”  Total fiber is the sum of DF and FF (IOM, 
2002b).  Having a two component model recognizes the importance of traditional diets in DF and 
their health associations, as well as recognizing the interactions that conventionally have been 
inferred to fiber, and applies to a wider variety of gut active compounds.   
Dietary fiber is not well defined and controversy exists in not only which, but how much 
of each type of fiber should be recommended (Gordon & Goda, 2008).  Fiber is only measured 
by the AOAC International approved methods and thus, fiber content is dependent on those 
methods (Lupton, 2008).  Current Institute of Medicine (IOM) recommendations for both 
children and adults suggest 14 g/1000 kcal per day (IOM, 2002a).  The amount for children and 
adults is the same relative density.  However, this can result in rather large physiological doses in 
small children.  The amount for children and adults is the same relative density.  However, this 
can result in large physiological doses in small children.  Current IOM recommendations for 
children 1-3 years old are 19 g/day as an adequate intake.  Reviews are still not conclusive with 
strong evidence on the relationships due to the types of studies conducted (ADA, 2008a).  More 
evidence contributing to specific contextualization of DF would likely eliminate some of the 
ambiguous variance with these results and reinforces the need for more research to identify the 
underlying mechanisms involved with DF consumption.      
Increased attention is aimed towards children (IOM, 2011) in order to provide a healthy 
base, intending to prevent associated problems as children are following the same path as their 
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adult counterparts (Ogden, Carroll, Curtin, Lamb, & Flegal, 2010).  Fiber has been identified to 
prevent and treat obesity in adults (ADA, 2008c), as well as youth (ADA, 2008b; Gropper & 
Acosta, 1987; Kimm, 1995).  Evidence suggests that children are not consuming enough fiber, 
both in the United States (ADA, 2008c; S. Kranz, 2006) and around the world (Glackin, Faser, & 
Neill, 2008; Lee, Ip, Chan, Lui, & Young, 2008) according to current recommendations.  This 
finding is not surprising as most adults are not consuming enough fiber either, both in the US 
(ADA, 2008c) and elsewhere (Lang & Jebb, 2003; Pohjanheimo, Luomala, & Tahvonen, 2010).  
Integrating fiber into the diet is recommended for improved overall dietary quality (IOM, 
2002b); however it is also recognized that empirical and mechanistic research regarding 
implications of its consumption are lacking, especially in children (Aggett et al., 2003; Sibylle 
Kranz, Brauchla, Slavin, & Miller, 2012).  The lack of evidence is not new (Dwyer, 1995).  
Addressing the importance of non-digestible carbohydrates in the diets of young children has 
been discussed (Aggett, et al., 2003) and currently others have noticed the extrapolation of data 
from adults to children (Sibylle Kranz, et al., 2012).  Common perception is that fiber is 
necessary for dietary quality and thus, good health. This inference has been noted in the literature 
(Munoz, Krebs-Smith, Ballard-Barbash, & Cleveland, 1997) that children “should progress to 
this kind of pattern,” (USDA, 1995) as well.  However, this is currently a moving target that is 
not well defined and ambiguity will continue to plague deeper inferential understanding.        
Findings in adults show they are not consuming enough fiber, which may be contributing 
to many conditions, such as: type II diabetes (Ventura et al., 2009), weight status (Cheng et al., 
2009), cholesterol metabolism (Queenan et al., 2007), colonic health (Burkitt, 1974), cancer 
(ADA, 2008c; Rose, Demeo, Keshavarzian, & Hamaker, 2007), cardiovascular disease 
(Mozaffarian et al., 2003), blood pressure (Burke et al., 2001), and energy intake (Flogan & W, 
2010).  Children have been hit with similar maladies that only adults were traditionally known to 
acquire.  Two disease of increasing concern in children are obesity (Kimm, 1995)and Type II 
Diabetes (Fagot-Campagna, 2001).  Thus, there has been increasing attention at solving these 
emerging burdens on health starting in young children all around the world (Gortmaker et al., 
2011).     
The complexity of the challenges that face DF consumption lend credence to the 
necessity of further metabolic research to root out mechanistic mechanism that may be occurring 
to contextualize noted associations.  Until recently, studying in-situ mechanisms has not been 
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feasible or unethical to complete.  One of the largest metabolic organs in our body was not 
recognized as such until recently, the large intestine.  The role of the large intestine was one 
solely of water and salt absorption.  The term “microbiome” has been coined (Mullard, 2008) to 
describe the vast interactions that occur between the host, the microflora, and the possible 
genomic interactions.  The vast microflora that inhabit the large intestine offer a major “middle 
man” to many of the previously observed roles of DF.  It is logical to believe that most 
relationships regarding fiber are conceivably measurable interactions with the microflora and 
their metabolism of DF (Harris & Kris-Etherton, 2010; Nilsson, Ostman, Preston, & Bjorck, 
2008).  Understanding the relationships currently known and the interactions of the colon, along 
with its microscopic host, may provide keys to understanding the “black box” of fiber.      
Thus, in order to provide scientifically sound and responsible advice involving the consumption 
of DF in children, it is likely that the gut and all it entails must be a central component in further 
analysis.  The overall objective of this research was to discover a gap in knowledge and use 
scientific methods to provide evidence to narrow this gap.  In reviewing the literature, it is clear 
that there is a large gap in basic knowledge of the nutritional component DF and its metabolic 
consequences, especially those concerning children.  Moving forward it is important that we 
understand basic mechanisms that may drive interactions of DF in a measureable, standardized 
way.  Thus, it was important to study “free-living individuals,” in reference to current dietary 
guidelines.  In order to ethically study humans, especially children, non-invasive techniques are 
central.  Therefore, the overall goals with this research were to incorporate existing non-invasive, 
gentle, and user friendly methods in an applied manner in children, while investigating 
mechanistic metabolic interactions of DF consumption with regard to the DRI’s.  Collectively, a 
basic understanding of DF interactions in the body could have major implications for the future 
public health.   
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Chapter 2 - Considerations in Developing Fiber Recommendations 
in Children: Implications for Health and Science 
 Abstract 
 
Given its implications on health, dietary fiber intake is a topic of major interest in 
nutritional research.  Currently, recommendations in children are reflective of and extrapolated 
from adult data and evidence is lacking to illustrate health outcomes in children.  In addition to 
better understanding the health outcomes of dietary fiber in children, consensus regarding the 
definitions of fiber is needed as the use of differing definitions creates a challenge regarding how 
health outcomes are assessed. Furthermore, sound definitions are critical for establishing 
approved methodologies and to accurately update nutrient databases to significantly enhance our 
knowledge of fiber’s influence on life-long health.  While evidence is scarce in children 
regarding the impacts of fiber on health, there is reason to believe that postulated mechanisms in 
adults are justified in children.  More information regarding fiber’s role in glucose and lipid 
metabolism is necessary, and should be extended to healthy children versus studies in non-
healthy populations.  Gut bacteria may provide valuable insight as disease indicators or inherent 
genetic differences that cause diseases, which will offer new prevention and treatment options.  
The collective genome of the microbiota and the host together create a significant complexity in 
the potential health effects that can occur.  Fiber is considered a principal source of fuel for gut 
microbiota and thus may drive several health outcomes, through microbial adaption.  This is an 
intriguing concept, but caution must be taken as it is difficult to determine the meaning of new 
associations.  To better understand the role of gut ecology on whole-body health, more research 
needs to be conducted that investigates mechanistic/causative factors.  Elucidating why an 
association is occurring is a difficult task, but is important if we are to fully understand the 
necessity of dietary fiber and its specific recommendations for children and their subsequent 
health status. 
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 Introduction 
 
 The prevalence of overweight and obesity in children is a major public health concern (1, 
2).  In fact, there is great concern over implementing and resolving what scientist have coined, 
“The Obesity Epidemic,” both in the United States and the world abroad for all ages (3, 4).  
Many researchers have suggested dietary fiber (DF) plays a protective role against obesity in 
children (5-9).  In addition to fighting adult-onset obesity, fiber consumption has been exhorted 
to benefit other conditions such as: cardiovascular disease (CVD), type II diabetes, cancer (breast 
and large bowel), constipation, and colon diseases (10).  Thus, fiber supplements (8) and 
functional food supply (11) are also becoming more common in today’s food market to help 
consumers increase their intakes of DF.     
 Campaigns and recommendations to increase fiber intake for a health benefit are not new 
and have been around for some time (12, 13).  In an upstream approach, children are increasingly 
becoming the target population of health promotion campaigns as nutrition and food quality is 
important for proper development (14).  Evidence suggests that the proper nutrition from the pre-
natal stages into weaning may play a larger role than previously thought in providing an “ideal” 
base (15).  Thus, nutrition during these early years of development has been considered 
important for a foundation of adult health and a life-course approach should be considered (16, 
17).  Therefore, it is important to have sound scientific evidence for dietary guidelines for adults 
and children.   
 Current recommendations of DF intake in the United States for children older than one is 
set at 14g/1,000 Kcal, which is considered an adequate intake (AI) (18).  However, scientific 
evidence pertaining to DF intake from children as young as two is scarce and inconsistent, with 
most data being recorded from adult studies (14).  Common perception is that fiber is necessary 
for dietary quality and thus, good health and children should progress to this kind of pattern (19). 
It is understood that evidence investigating DF in children is lacking (20, 21), and attempts have 
been made to try address the paucity of data (22).  
 Addressing the importance of non-digestible carbohydrates in the diets of young 
children has been discussed (23) and currently others have noticed the extrapolation of data from 
adults to children (24).  However, the research discriminating inconsistencies and reaching 
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agreement on issues has been slow.  The goal of this review is to address the complexity 
surrounding DF recommendations, and its consumption and implications to human health, 
specifically in children.  This review will outline the current definitions and challenges in 
defining DF, sources of DF, DF intake recommendations, metabolic evidence and a discussion 
on the role microbiota could play in determining health implications. 
 Definitions 
 When discussing benefits in relation to health it is critical to first have a consistent 
definition.  One of the most ominous challenges facing policy and dietary advice in regards to 
DF is defining it.   Thus, to accurately describe the impacts of fiber and measure any outcomes 
associated with fiber, it is important that we better define what classifies as fiber and what does 
not.  The Institute of Medicine (IOM) has summarized the definition of DF, when no less than 20 
distinct definitions are currently used around the world (14).  Recently, issues defining the 
consumption of DF for nutritional benefit have included:  nutritional status, biochemical 
functions, physiological functions, dietary quality, nutritional quality, and quality of life (25).  
Major hurdles in assessing the impact of dietary fiber and analysis in children are contingent on 
future definitions and subsequent public policies.  If an acceptable definition of DF is not 
established, then assessing clinical and public health implications of DF will remain difficult.  
This section of the review will not focus on policy as it defines dietary fiber; however, it will 
cover current understanding of major classes of carbohydrates and analogous compounds used to 
classify fiber.       
 Current U.S. Definitions 
 In the United States, the IOM has currently defined total fiber (TF) as a function of two 
components.  The first component of DF pertains to its physical characteristics and has been 
defined as: “Dietary Fiber which consists of isolated, non-digestible carbohydrates and lignin 
that are intrinsic and intact in plants.”  This first definition is more consistent with philosophies 
intended by Hipsley (12) and later Burkitt (13). However, understandings of fiber and 
physiology have warranted additional profiling regarding health outcomes and claims.  The 
second component pertaining to the functional attributes of DF have been defined as: 
“Functional fiber consists of isolated, non-digestible carbohydrates that have beneficial 
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physiological effects in humans.”  Total fiber is the sum of DF and FF (18).  Having a two 
component model recognizes the importance of traditional diets in DF and their health 
associations, as well as recognizing the interaction that conventionally has been inferred to fiber, 
and applies to a wider variety of gut active compounds.  Currently, the Food and Drug 
Administration (FDA) has not adopted the IOM’s recommended fiber definition.    However, 
current nutritional labeling principles do not incorporate the principles of the bacteria’s residence 
there and the total functionality (26) and thus, are of limited use for public application and 
incorporation.  It is possible these labels may be considered misleading to the public’s general 
perceptions (27) and embodies the importance of setting consistent definitions.  
 Noncarbohydrate Sources 
 As defined by the IOM in 2002, there is both DF and FF, which can include 
noncarbohydrate sources.  These substances are not isolated from “DF” but in fact may 
contribute to their cited effects.  Components of fiber including lignin, phytate, oxalates, and 
saponins would likely be difficult to ever distinguish in-situ (28).  Furthermore, normal 
household food preparation parameters, such as cooking, likely increase the production of 
Maillard products, which are not digested in the small intestine (SI).   
There are several sources of functional fiber, which have an impact in the large intestine 
(LI) and are independent of carbohydrate such as: chitin, chitosan, and endogenous sources (i.e. 
protein, lipids).  Chitin is a non-carbohydrate source that is a component of plant cell walls, 
insect exoskeleton, and crustacean structure.  The structure includes β 1-4 linked glucose and 
differs from cellulosic and β-glucan structure by the addition of N-acetyl amino group at the C-2 
position of the glucose residue (29).  A derivative of chitin, chitosan, is a form of chitin in its 
deacetylated form.  Interestingly, chitin is insoluble and viscous, with a high molecular weight.  
Therefore, it seems logical there are many substances that may demand attention when trying to 
understand the implications of non-digestible materials to be included in DF.        
 Mono and disaccharides 
 Typical discussions surrounding mono and disaccharides are not associated with fiber.  In 
normal gastrointestinal (GI) function monosaccharides such as glucose, fructose, and galactose 
are considered to be completely absorbed in the SI.  In younger children, where the digestive 
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tract may still be developing monosaccharides have been noted to induce breath hydrogen 
production after ingestion.  Thus, this seems to indicate that a normally absorbed carbohydrate in 
an adult may actually serve as a functional fiber in young children (30, 31).  Dysfunction of the 
GI tract involving monosaccharide digestion has been described as an issue of “over-load” or 
“malabsorption” where the monosaccharide passes to the LI and becomes available for 
fermentation (32).  This is indeed the theory behind the common clinical practice of 
carbohydrate malabsorption in young children (33).  The common dietary disaccharides sucrose, 
lactose, and maltose are completely digested and absorbed in the “normal” SI; however, this 
varies with population (33).  These disaccharides can also contribute to intolerances which are 
well noted in the scientific literature (34).    
 Oligosaccharides and Polysaccharides 
Oligosaccharides (OG) are carbohydrate polymers that consist of multiple 
monosaccharide units that vary in definition.  Oligosaccharides are consistently characterized by 
greater than two monosaccharides and nondigestible; but have also been labeled as short chains 
of monosaccharide units (35), three to ten monosaccharide units (35, 36), two to ten polymers of 
monosaccharides (37), and three to nine monosaccharides (38).  Common short chain OG 
include raffinose (trisaccharide), stachyose (tetrasaccharide), and  verbacose (pentasaccharide).  
These short chains often are not hydrolyzed in the SI by human digestive enzymes, thus making 
them available to the LI and available for fermentation by the resident microbiota.  These OG 
serve as prebiotics and have been shown to increase gut bacteria, and are considered to be 
beneficial and to positively impact young children (39).    
In addition to short chain, longer chain OG have been found to be an increasingly 
important part of infant nutrition (40).  Longer chain OG are frequently in the 2 to 60 unit 
polymer range.  Typically, these longer chain OG are chemically speaking laden with fructose, 
which can be called polyfructans(29).  Common specific terms for long chain OG include: 
polyfructose, inulin, oligofructose, and fructooligosaccharide (FOS).  In fact, these longer chain 
OG seem to provide significant importance in the nutrition spectrum of younger children and 
infants from natural sources.  Polyfructans are generally found in chicory, asparagus, onion, 
garlic, artichokes, tomatoes, and bananas.  In addition, breast milk is an important source of OG 
that provides many health benefits (41).  However, recently it has been observed that human 
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breast milk may be an important source that preferentially stimulates Bifidobacteria (40).  
Oligosaccharides processed and collected from plant sources are used in foods as a texture 
improver or substituted for other ingredients due to their functional properties.           
 Starches 
   Traditionally, starches are composed of two distinct groups of alpha-glucan, amylose and 
amylopectin.  As recently as 1987, a food component was measured as nonstarch polysaccharide 
(NSP), but was a starch fraction and was confirmed in ileostomate models to escape SI digestion 
(42, 43).  These starches were identified as resistant starch (RS), aptly named for their ability to 
resist digestion in the SI of man.  A formal definition of RS was achieved during EURESTA 
proceedings, “the sum of starch and products of starch degradation not absorbed in the SI of 
healthy individuals” (44).  As such, RS is viewed more as DF or functional fiber as classified in 
the United States.        
Amylose and amylopectin starches are characterized by α 1-4 and α 1-6 glycoside bonds 
of D-glucose that are readily digested by human SI digestive enzymes.  In most conditions 
amylopectin is present in higher proportion than amylose at 80%-85% and 10-15% respectively.  
Current opinion suggests that starch structure impacts their ability to be digested and thus their 
“availability” (45).  Amylose has been noted to be less digestible compared to amylopectin, 
where metabolic response is reduced with increased amylose content in rice (46).  This has also 
been noted with microorganisms’ ability to ferment substrate (47).  Some mechanisms identified 
surround the potential ability of amylose to retrograde or complex with other compounds (46).   
Resistant starches are present in four groups that are profiled by their presence in the food 
supply.  Presence is a function of source or structure, which can be facilitated by processing (48).  
Type 1 (RS1) is defined by the physical entrapment of the starch within cell walls that render it 
indigestible to human digestive enzymes.  Sources of RS1 would include grains and seeds that 
have gone through limited milling or none at all.  Type 2 (RS2) can be characterized by granules 
of starch that are not heated or gelatinized and remain resistant to digestive enzymes.  Common 
sources of RS2 include raw potato starch and unripe (green) bananas.  Type 3 (RS3) is referred 
to as “retrograded starch” which is produced by wet cooking with subsequent cooling.  Cooling 
is important as it allows the starch helices to recrystallize, which portions become unavailable to 
digestive enzymes.  Type 4 (RS4) is synthetically produced resistant starch, which goes through 
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chemical modification allowing polymers to cross-link and become resistant to normal digestive 
enzymes.  Recently a new RS has been defined which is being labeled RS type V (49).  Type V 
is starch that is complexed by an amylose-lipid interaction (50).  According to IOM definitions, 
RS1 and RS2 would be considered DF with RS3, RS4, and type V, being functional fiber.  
Resistant starches have received much attention in scientific literature in regard to their potential 
in prebiotics (51).  Thus, RS may provide a functional ingredient for foods that younger children 
are likely to consume and provide glycemic control.   
 Analogous Carbohydrates 
 Carbohydrates that are synthetic or result from processing, but mimic natural DF and 
retain the physical properties of the natural counterpart are termed “analogous.”  Typically, these 
carbohydrates can be produced through food processing, and include: indigestible dextrins 
(maltodextrins from corn and potato dextrins), synthesized carbohydrate compounds 
(polydextrose, methyl cellulose, hydroxpropylmethyl cellulose), and resistant starches can be 
categorized here as well (36).  The definition of DF has progressively acknowledged the 
physiological implications, which may continue to enhance the importance of analogous 
carbohydrate in the diet.  Common uses of these products include thickeners and sweeteners (52) 
and may represent a significant source of fiber currently not accounted for in young children.   
 Dietary Fiber Intake 
 Fiber consumption begins as soon as children start to feed early in infancy.  In fact, it is 
believed that the first sources of DF are lactose, fructose (31), OG and starch (53).  The earliest 
studies reporting intakes in children were recorded almost 30 years ago (54) and have not shown 
much of a change over time.  In data gathered during 1976-1988 for the Bogalusa Heart Study it 
was found that children 10 y and 13 y maintained intakes of DF and decreased in density with 
age.  Additionally, black children consistently consumed more fiber than white children with an 
overall mean intake of 12 g/day or 5 g/1000 kcal (54).     
Reported fiber intake is universally less than recommended, regardless of assessment 
method or guideline. Data examined from National Health and Nutrition Examination Survey II 
(NHANES II) using 24-hour recalls, reported that DF consumption from 3-5 years and 6-11 
years, had mean/median intakes of 10.7/9.8, 12.5/11.1, respectively (55). In addition, the 3-5 
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year old group consumed 1591 kcal/day on average with the 6-11 year old group consuming 
1897 on average (56).  This corresponded with a DF density of less than 6.7 g fiber/1,000 kcals 
for 3-5 year olds and 6.6 g of fiber/1,000 kcals for 6-11 year olds.  Currently, these are all well 
below the, “Age + 5”, AI, and AAP recommendations.    
In 1991, average DF intake for children (4-19 y) was found to be around 12 g/day, with 
the 4-7 yr. age group reported to eat approximately 10.5 g/day (57).  This reflected around 6% of 
the fiber from cereals and vegetable fiber, which was primarily obtained during snacking, 13% 
from breakfast and the rest from major meals (57). Current recommendations suggest 14g/1000 
kcal, while in this study it was found to be around 6 g/1000 kcal or about 50% below 
recommendations and it declines with age.  In a cross-sectional study of Native American 
children and non-hispanic white children 1-6 years in age were found to consume similar levels 
of DF with only 6% coming from fruit.  Significant foods contributing to fiber content in the 
vegetable category were beans and corn (58).        
 Another large survey, the Continuing Survey of Food Intakes by Individuals (CSFII) has 
shown similar results as the NHANES data.  For instance, dietary data analyzed from the 1989-
91 CSFII found that children (4-6 y) consumed 45% of DF recommendations assessed by the 
Age + 5, guideline (59).  As children aged (7-10 y), intakes meeting recommendations were 
reduced to 32%, and is in accordance with other studies (57), who found a decrease in fiber 
density with age and approximately a 2 g/day increase up to 19 years of age.  A more recent 
study evaluating pre-school children (2-3 y and 4-5 y) with CSFII 1994-96, 98 surveys found 
that fruit and legumes were the largest contributor to fiber intake (9.9 g and 11.5 g, repectively) 
(20).  Neither guideline the Age + 5 (which is less than the AI) or the DRI was met for DF intake 
this population.  More recently, data has supported past low intakes, finding children still under-
consume recommendations with an average of 11.1 g/day (60).  
 Interestingly, only 12% of children were found to meet relative recommendations, and 
lower socio-economic status was actually associated with increased fiber intake and nutrient 
density, according to DRI’s (61).  However, not all studies show the same consistent results 
regarding socioeconomic status.  Recently, a study in Flemish children (2.5-6.5 y) found most of 
their DF intake came from breads and cereals (30%); however, DF from fruits and vegetable 
sources were found to increase only with maternal education and parental employment status 
(62).    
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Data are available in the younger populations assessing the adherence to DRI’s, including 
fiber intake.  A national survey of primary caregivers using a 24-hour recall reported that DF was 
less than recommended (according to CDC median values for EER estimation) in toddlers (12-24 
months) and preschoolers (24-47 months), with 9 g and 10 g, respectively (63).  This was in 
accordance with earlier evidence from the same on-going data set indicating that children in the 
1-2 yr group were not meeting AI recommendations (19 g/d) of DF intake in 2002 (64).   
Children may be more likely to consume fiber if breakfast was consumed.  A lack of 
breakfast consumption has been implicated with reduced fiber intakes in several studies 
involving children.  In young (9-10 y) African American and white girls, eating breakfast was 
positively correlated with increased fiber intake (65).        
Although not a measure of DF, glycemic index (GI) and glycemic load (GL) are 
sometimes used as a proxy for its consumption.  This is based on the premise that lower GI foods 
tend to be higher in DF.  In a study involving young (7-8 y) German children, researchers found 
that cohorts from 2002 reported food intakes with higher GI values than their predecessors in 
1990 (66).  In addition, this study found that “tolerated food groups” such as sweets, candies, and 
refined starches, were largely responsible for the GL of the diet, with potatoes only accounting 
for ~4% of the GL in the diet.  This fits well with the idea that eating lower GI and GL foods 
may provide increased nutrient consumption including DF.  Interestingly, in populations where 
control of glycemia is important, such as those afflicted with Diabetes Mellitus (DM), increased 
fiber intake may be important and higher motivation might exist in this population towards 
adherence to increased fiber consumption.  A study in adolescents (13-19 y) with Type 1 DM 
reported youth with Type I DM consumed more DF (21 g boys, 17 g girls) than non-diseased 
peers, but still less than recommendations (67).  It should be noted that numerically their intakes 
were higher than other reported studies, but there was a large statistical variation in this 
population and was only statistically significant compared to national surveys.     
While some studies have investigated DF consumption, others have focused on the 
availability of DF as proxy measure for assessing dietary quality which provides some insight 
into DF intake.  Researchers observing household availability of nutrient status (Nutrient Status 
Adequacy Ratios) found that most nutrients were available in households at DRI 
recommendations consistently across weight status except for DF, carbohydrate, and calcium 
(68).  However, this study leads little insight into the flux of foods through the household, which 
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is a serious limitation.  In addition, the authors mention limitations in regards to knowing which 
foods were consumed or wasted.  Thus, measuring the availability of fiber is likely to always be 
limited by similar pitfalls and makes any kind of inference from the data highly speculative.  
However, this type of evidence presents an affordable way to add data for helping assess where 
barriers lie in understanding fiber consumption and the ultimate impact on health.     
 Dietary Fiber Recommendations 
 Young children over the age of two do not consume recommended amounts of fiber.  
This may be setting the stage for DF intake into the adult years (18). Determination of DF intake 
in children has been evaluated via two guidelines, Adequate Intake (AI) as recommended by 
FNB (18) and the, “Age + 5,” recommendation (53).  Each guideline is intended to achieve adult 
levels of fiber intake by the age of 20, when demarcations to adulthood are set.  Other guidelines 
that are utilized include: the American Association of Pediatrics 0.5 g of DF per kg of weight, 
the calorie based (21) FDA food label guideline of 25 g/2000 kcal (12.5 g/1000 kcal) and 30 
g/2500 kcal (12 g/1000 kcal), and the IOM recommendation of 14 g/1000 kcal.   
 
 Physiological Considerations with Fiber Intake 
 Providing proper recommendations for DF intake in children will require more research 
in the youth population.  As previously noted, most of the recommendations are extrapolated 
from adult studies and are likely to have similar benefits.  However, it is critical to understand 
the implications specifically within the population studied.  The intent of this section is to shed 
further light on the current available evidence regarding physiological factors of DF on health in 
children.  Information surrounding children, regarding other metabolic considerations are 
available, but not covered here: obesity (21, 24, 69), laxation (21, 70), and satiety (21).  Glucose 
metabolism, lipid metabolism, and constipation will be the focus of the following portion of the 
review.   
 Glucose Metabolism 
 Evidence regarding the implications of DF on glucose is readily available with adults as 
subjects (71, 72).  Evidence in children is much less prevalent, but seems to be suggesting 
similar mechanisms as in adults.  In adults, meta-analysis through prospective cohort studies 
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suggest cereal (grains) fiber consumption and magnesium intake decreases the risk of diabetes 
(73).  Furthermore, a review by American Dietetic Association (ADA) (74) shows limited 
evidence implicating 30-50 g DF/day in reducing serum glucose levels compared to groups with 
low-fiber diet.  In addition, it is suggested that daily intakes of 10 -29 g of fiber supplement may 
provide beneficial effects for glycemic control.  However, the mechanism of action controlling 
this outcome is debatable and more research is needed to confirm these effects, especially in 
children at risk for developing insulin resistance.  Children are often implicated in the same low-
nutrient dense diet of adults (75) and considered at-risk for suffering the same maladies.   
 Studies examining the effects of DF intake on blood levels of glucose tend to show a 
general decreased post-prandial response following higher fiber intake, with psyillum fiber being 
one form of DF reported to decrease post-prandial glucose (76).  Specific to children, in 
overweight Latino adolescents (10-17 years old), an increase in fiber intake elicited increased 
insulin sensitivity (77).  While data do exist, more research needs to be conducted to determine 
impacts of fiber on glucose metabolism in children, especially longitudinal studies.  The research 
that does exist has typically been focused on those with Type I diabetes (78) and needs to be 
expanded to the larger population of children to determine the capacity of DF at preventing 
metabolic disease.  This would allow for more information in the assessment of the necessity of 
fiber in the developing child, or its’ lack of consumption, in the development of disease.  
Furthermore, this could potentially lead to insight into how younger bodies utilize glucose 
compared to adults.  Only a few studies have tried to assess the impact of isolated types of fiber, 
such as soluble versus insoluble.  In a clinical trial, children fed a high dose (~30g, 4 g soluble) 
experienced decreased fasting serum glucose compared with those eating a low dose (~10 g, 1 g 
soluble) (79).  
Acute consumption of DF suggests a role in controlling post-prandial glycemic response.  
This has been translated into long-term intake in the DONALD study in German children.  Fiber 
intake was found to significantly decrease across increasing glycemic index (81).  Collectively 
with other measures in that study, it would seem fiber intake displaced rapidly absorbable 
carbohydrate, which may have impacts on glycemic control.  In a study of overweight 
adolescents, “sugar” (or sucrose) was suggested to be responsible for the adiposity gain and 
reduced insulin sensitivity (81).  When the GI and GL were measured, they did not explain much 
18 
 
of the variation.  Conversely, in adults, research has seen fiber as an independent factor regarding 
glucose metabolism and needs to be accounted for in analysis of glycemic control (82).  
 Lipid Metabolism 
 In adults, evidence regarding the implications of fiber in lipid metabolism is abundant 
and seems to play a significant role (83). Fiber seems to impact the way lipids are metabolized in 
the body, potentially mediating health outcomes (84). Evidence in children is also indicating that 
fiber may play a similar role in altering lipid metabolism.  In a recent study in Finland, children 
were found to consume more fiber with increasing food intake, while fat intake was inversely 
correlated with fiber intake (85).  Furthermore, as in adults (83), serum cholesterol was found to 
be inversely correlated to fiber intake.  Children fed high (~30 g, 4 g soluble) versus a low (~10 
g, 1 g soluble) fiber diet experienced decreased serum LDL concentrations by approximately 
12% compared with the low dose (79).  Soluble fiber was defined as pectins, gums and 
mucilages.  Another study of hypercholesterolemic children following a 3 month lead-in low fat, 
low cholesterol diet, provided psyllium fiber (3 g) for 8 weeks had no significant alterations on 
blood serum cholesterol from baseline (86).  More evidence is needed to confirm associated 
findings and to translate more specific relationships that exist with level of fiber intake and fiber 
type.   
 Constipation 
Low fiber intake seems to be associated with several deleterious conditions, suggesting 
that increased intake may decrease the occurrence of unwanted bowel outcomes such 
appendicitis (87) or constipation.  Constipation is a major cause of children’s visits to the 
hospital, with approximately 5% of outpatient visits being diagnosed as such (88).  An estimate 
of constipation prevalence suggests that it affects from 0.7% to 29.6% of children in different 
regions throughout the world (89).  Complete diagnostic criteria of defecation disorders 
including constipation can be found under ROME III guidelines, which are more inclusive and 
have shown a higher prevalence than reported with the previous ROME II criteria (89, 90).  
Constipation has been defined by the parameters of difficulty passing a stool or by less than 3 
bowel movements per week (91, 92).  Much research involving children has focused on fiber’s 
role in amelioration of these indicators or symptoms.      
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Several studies involving Chinese children have tried to assess the impact of fiber level 
on constipation.  In a study in Chinese children (3-7, 8-14 years) recommended DF intake of 10 
g and 14.5 g, respectively for the relief or amelioration of constipation (93).  Another study 
involving Chinese children found that mean intake was only 4.1 g/d in pre-school children in 
Hong Kong (94).  However, that intake was about half the level consumed by children in the 
Chao et al., (2008) study.  Furthermore, the American Academy of Pediatrics (AAP) only 
recommends that 7-10 grams per day should be consumed for these age groups.  According to 
their definition 10 g should be sufficient to prevent constipation.  It should be noted that the 
intake in these children was more than double those in Hong Kong, both occurring in Chinese 
populations.  Conversely, if we use the IOM recommendations then neither group obtained the 
recommended intake of DF 19 g/day.   
In children with constipation, fiber intakes were not meeting the recommendation of 
“Age + 5” (95).  Low fiber intake has been reported in many other countries as well.  In Irish 
children (ages 5-8 years), 76% did not meet recommended guidelines for fiber intake; however, 
only 13.6% of the children with low DF intake developed constipation compared with 6% of 
children  who reported adequate fiber intake (96).  Clearly, there is an association between fiber 
intake and presence of constipation.  However, this association does not necessarily implicate DF 
in the etiology of constipation nor does DF seem to completely resolve constipation (97).  In fact, 
63% of individuals who did not consume enough DF were considered as healthy as the 94% who 
were able to meet recommended doses.  Research has also shown that associations exist in 
constipated children both with DF intake of less than, equal to or higher than other children who 
are not constipated.  Thus, fiber does not seem to be the most significant factor regarding the 
presence or prevention of constipation.   
With that said, DF is often an included in treatment for constipation (98). Considering the 
mixed results with DF’s ability to treat constipation, we must be careful how we characterize 
fiber and be specific about the types of substrate used to label as “fiber.”  Indeed, fiber may be a 
successful treatment option (24, 99, 100).  However, this information should be taken in context, 
as very rarely are fiber treatments (glucomannan, lactulose) given as the first and only treatment 
and some recommend that DF be ingested concurrently with other treatment options as 
constipation is a multifaceted condition (98).  Moreover, the American Academy of Pediatrics 
(AAP) seems reluctant to advise a definitive supplement of DF intake to treat constipation.  
20 
 
There are many components that need to be addressed and it would seem logical that every case 
is different, which should be taken into account when treating constipation.     
In Brazilian children (6-8 y) with chronic constipation, daily DF intake was lower than 
normal controls, 13.8 g versus 17.3 g, respectively (101).  In children with chronic constipation it 
is well known that a cycle may be induced where children are afraid of passing stools and thus, 
‘hold the stool’.  This creates a painful process of large, impacted and dry stool that the child 
resists passing, further complicating and ensuring the cycle continues (98).  Another study of 
constipated Brazilian children found that children with higher bran intakes tended to have 
improved bowel conditions compared to those whose conditions worsened (102).  This study was 
not clear, though, on the “acceptance” of bran and its consumption.  The only measures of 
dietary intake were by food frequency questionnaires (FFQ’s), which should be considered with 
their limitations.  The authors were not clear as to the participants who were consistent and those 
who were not as aggregate data seems to be used at each time point instead of paired data.  
Nevertheless, some children’s symptoms did not improve, which again underscores the 
complexity of constipation management and that changing DF intake may not necessarily affect 
symptoms.     
Fiber alone has been noted to not be sufficient in the treatment of constipation and may 
require a broader individualized approach.  One question that still needs to be addressed is 
whether low DF intake noted in constipated individuals is, in fact, a response to additional 
compaction they may feel.  If a child is fearful of bowel movements, then higher fiber foods may 
not be appealing.  It would seem logical that children who consume fiber may feel more pressure 
with increased load to the LI and still be fearful, compounding the eventual voiding and 
potentially creating a more uncomfortable experience.  In addition, children may associate this 
additional pressure with DF intake and avoid its intake.  However, more research should be 
conducted to determine if indeed these factors could play a role.  Due to the complexity of this 
condition, it is debatable whether an increase of three grams of fiber (the gap most of these 
studies show) would create a more desirable situation for a functionally constipated child.                
 Children, Fiber and Gut Microflora 
Many reviews are available discussing the metabolic consequences of fiber (8, 14) 
primarily in adults.  However, there are few that discuss DF’s relationship in children.  It has 
21 
 
been recognized that information regarding the impacts of fiber in children is often an anticipated 
outcome extrapolated from adult studies (24) and more research should be undertaken to confirm 
these relationships in children (20, 22, 23, 39).  A life-course approach seems to be the agreed 
upon method of health advice (17, 22), but when making recommendations, credence should be 
given based on the accumulation of data.  Caution should be heeded (103) in order to make a 
consistent recommendation so that the public can endorse consumption as it meets their 
individual circumstances.   
Still, DF’s impact on health is not fully understood or complete, with many reviews 
covering this topic (104) in adults (8, 103) as well as children (23, 24, 39, 105).  It is likely that 
many health-promoting qualities of fiber are similar in children as adults such as: bulking agent, 
moisture retention and physical blocking of interaction of substrate and human digestive 
enzymes.  However, one area that warrants further discussion is the belief that fiber acts as a fuel 
source for colonic bacteria and they may indeed contribute much more too human health than 
anticipated (106-108).  However, it is important to discuss the role each of the mechanisms play 
in the role of the developing gut of children.  As the previous reviews have targeted some 
metabolic outcomes, it is the goal of this review to focus more towards gut microbiota.  
   Currently, fiber holds the most intrigue and potential for contributions to the 
understanding of gut health.  This is in regards to its utilization as a fuel for the microflora in the 
LI.  As fiber is not digested by human pancreatic enzymes in the SI, it is made available for 
utilization by bacteria in the LI and the microbes that reside there (109). Research has 
determined that the bacteria in the LI need 60-70 g of substrate everyday (110, 111) in order to 
maintain estimated populations.  This can be further broken down into approximately 8-18 grams 
of fiber in addition to starch (8-40 g) (112).  These populations are so large that the bacterial 
cells outnumber the somatic host cells ten-to-one (113).  More notably the collective genome of 
the resident microflora is estimated to contain in the millions, compared to only 20,000 in the 
human host genome (106).  This makes the potential for interactions from the host to its residents 
enormous and likely a significant factor.   
Most animal species thrive from their mutualistic relationships with the microbiota 
inhabitants, thus making it very likely the human animal is not completely unique (113, 114).  
Research regarding the investigation of the microflora and their complete roles in the nutritional 
world are exceedingly high.  Recently, technology has made it possible to further investigate the 
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impacts of the microbiome (106).  So much so that $115 million alone in the U.S. and another 
$70 million in research funds are being provided for simply the mapping of such genes and 
potential interest in disease (106). It is logical that if researchers want to begin to understand the 
role of colonic health, especially in developing child gut it must go through the microbiota that 
reside there and all the interactions that could take place.   
Typical microbial species of interest include: Bacteroides, Clostridium, Desulfovibrio, 
Lactobacillus, Escherichia coli, Enterococcus, Fusobacterium, Bifidobacteria and the archae 
Methanobacter.  Indeed, evidence indicates that microbial species are substantially influence by 
dietary habits (115) or substrate available in children (116).  When children were studied 
longitudinally, differences between the rural and the urban children’s gut microbial populations 
were noted (117).  These bacteria and their substrates together form a complex interaction that 
may have health implications such as colon cancer, allergies, obesity and inflammatory bowel 
disease associated with a Westernized diet (118).  Central interest has surrounded the difference 
in microecology in individuals with metabolic syndrome, obesity, abnormal glucose and insulin 
responses, cholesterol, and altered immunity (119-122).  Thus, this leads to the expectation that 
modulating diet may provide beneficial alterations in gut microbiota that will lead to improved 
health outcomes (123).       
To better understand the impact of the developing gut, more specifically the LI in 
children, it is important to consider existing knowledge.  Traditional methods were often limited 
in their ability to detect total microbial populations (113, 124).  These limits were based on the 
ability to culture microorganism and were largely restricted to aerobic cultures.  As time 
progressed, anaerobic models were able to advance these culturing procedures opening new 
detection opportunities.  These resulted in estimates of approximately 400 species in major 
microflora (125).  However, there were still limited in the fact that we still had to have the 
technology to culture in order to study what exists.  With the advent of molecular techniques 
(126) which have become more cost effective in recent years, it has become quite clear that we 
only understand fractions of the total microecology that existed. These estimates suggest that 
approximately 20% of bacterial genomes are known or able to be cultured (127, 128).  
 Fiber intake in children suggests the when the child is developmentally ready they should 
begin consume fiber in order to establish important bacteria (39).  However, this time frame may 
be different for every child.  They should begin to develop the adult pattern as soon as possible 
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to prepare them for lifelong health.  However, do we want our children following the 
developmental pattern of most adults?  Children do not assimilate carbohydrates similarly to 
adults (53).  Perhaps this could be due to innate functional differences from adults, where 
children have smaller, SI’s which correlate well to body length (129).  Furthermore, the flow of 
colonic contents are an important mitigator of the ability of the bacteria to utilize substrate (113).  
Evidence also indicates that once substrate makes it to the colon, it is utilized in differentially in 
all individuals (130) and perhaps children exhibit differential characteristics.   
Differences in gut function are not well identified in the literature.  However, in children 
this may translate to a more efficient colon that utilizes more substrate (131).  This also appears 
to be the case in in-vitro models as well (132).  It is likely to be important then in children and 
adults alike to understand the role of constipation in alteration in gut microbiota in respect to 
substrate flow.  However, there is currently not enough evidence to elucidate whether current 
substrates (refined starches) that escape digestion in the young child SI is indeed 
developmentally necessary.  While energy is escaping the large intestine, it is possible that 
substrate evasion of the SI was necessary for gut development.  Allowing simple substrate to 
escape the SI and develop the gut may prepare the gut for less digestible substrate in the future 
and an enhance energy supply.  Perhaps, the progression of substrate could be important for 
optimal gut development.  As our understanding of the variety of unavailable carbohydrate (DF) 
increases the amount, as the type, and the outcome desired should be considered in making 
future DF recommendations.  Currently, there is not enough research to develop broad general 
recommendations that will contribute necessary functions for optimal health.   
To find what is necessary for well-functioning or optimal GI health with regard to 
children (~2 and older), clear goals must be set.   To profile and achieve optimal GI function 
with regard to the microflora several premises must be met:  1) Characterization of an optimal 
example of gut function; 2) Characterization of optimal microbiota that inhabit this gut; 3) How 
this microbiota came to be established in the gut (113, 133, 134) and 4) Can we modify an 
“unhealthy” gut to an “optimal” gut through addition of “optimal” parameters, such as fiber.  
These premises can be a framework with which to conceptualize the end target.  This final 
premise is of seminal importance if we believe DF to alter this microbiota to the said “optimal” 
state for life-long health.   
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Microbiota likely confer specific geno and phenotypical traits that benefit the human host 
beyond what could be achieved on their own (135).  Thus, for optimal health, having this “core 
microbiome” (136) that could confer the most possible health benefits would be the goal.  
Savage et al., (1977) extensively discusses the role of autochthonous organism or those that 
should normally inhabit the host’s gut.  In newborns (presumably all species) the gut is sterile or 
microbe free (137), with inoculation occurring to interaction with the environment.  These 
organisms which are first obtained at birth (vaginal, fecal, or cesarean) are most likely to be 
found in the intestinal tracts of infants (113, 138-141).  After initial inoculation dietary 
modulation appears to be the major factor contributing to development.   
Microbiota that are autochthonous are obtained from the environment, which includes 
microbes present on food that survive digestive forces and substrate for those already surviving 
that journey.  Notable changes in diet with alterations in available substrate have shown to 
produce variations in colonic microflora (142).  Microbial population differences are then noted 
in breastfed versus formula fed infants (143, 144).  Research has shown that formula fed infants 
are more likely to present an adult like microflora pattern (141).  Breastfed infants are more 
likely to stay centered around the Bifidobacteria that largely inhabit their LI (39).   
According to overall microecology, formula fed infants are better adapted for the next 
stage in life, weaning.  This is shown by the formula fed infants ability to ferment complex 
carbohydrates more quickly than breast fed infants (39).  This was confirmed by in-vitro analysis 
regarding breast-fed infants in different stages of weaning.  As on set of weaning was delayed, 
the ability of the infant microflora to ferment complex polysaccharides was also delayed (145).  
Alternatively, infants who were formula fed with a more adult-like microflora showed little 
trouble fermenting complex carbohydrates (146).  This suggests that earlier weaning, which 
requires consumption of other substrates (such as the formula fed), modifies the LI and prepares 
it for continual increasing complex substrate load.   The authors noted that this is not likely to be 
a large source of energy in the infant at this time.  It is important to recognize the complexity of 
the developing gut and the need for much more research to determine more optimal 
recommendations.   
In addition to substrate availability affecting our ability to more completely ferment non-
digestible carbohydrates (fiber), i.e. altering and modifying colonic microflora, our body seems 
to have a way to ensure that this population is indeed developed by substrate.  Recent evidence 
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has been able to confirm that infants indeed receive a constant source of fermentative substrate in 
the form of OS in breast milk (40).  As noted above, breast-fed infants are relatively slow in 
fermenting other complex carbohydrates.  Interestingly, FOS from breast milk seems to 
preferentially target Bifidobacteria longum and biovar infantis.  However, these are not the 
predominant bacteria in an adult LI (147).  This is contrast to Bacteroides, which is considered to 
have the greatest populations overall (147).  In addition, several studies have noted the wide 
adaptability of Bacteroides to utilize many fermentative substrates (148).  
When making specific DF recommendations it is necessary to assess if DF has the 
potential to alter microbial communities in a controllable fashion for the betterment of a child.  
Traditional thought has noted that the overall change in  microflora composition is not changed 
by dietary modulation (149). However, this study was conducted before the mass incorporation 
of molecular techniques.  One reason the microecology appear to not change is that Bacteroides 
have proven to be uniquely adept at utilizing a variety of substrates.  These substrates are only 
inclusive of some study outcomes: heparin, pectin, ovomucoid, amylose, amylopectin, dextran, 
gum tragacanth, gum guar, L. arch arabinogalactan, alginate, laminarin, psyllorium hydrocolloid, 
xylan, polygalacturonate, gum arabic, and cellulose (148).   
Nevertheless, diet is believed to play an important role in the modulation of the gut 
microbiota.  In newborn infants, a shift in the microbiota present can already be detected in 7 
days (143) towards Bacteroides fragilis.  This seems to follow changes from colostrum to more 
mature milk and substrate changes.  Traditional methods have illustrated a shift to Lactobacilli 
and Bifidobacteria as the predominating cultures towards one month of age (150).  When the 
time for weaning does come, there is some evidence that indeed shows shifts in the outcomes of 
health towards formula fed infants.  Studies have shown that when breast-fed infants are weaned 
there becomes a period of time where the infant is at risk for diarrhea independent of pathogen 
introduction (151).  This seems to confirm the pancreatic insufficiency of the infant to fully 
digest substrates and perhaps leading to an osmotic overload of the colon.   
What is deemed as an available carbohydrate or un-available in infants and children is 
different than what can be expected.  Excluding malabsorptive disorders for lactose, maltose, 
fructose, glucose and potentially small intestinal overgrowth; the gut is not as efficient at 
absorbing all nutrients as those found in adult profiles.  Christian et al., (53) reported that not all 
starch may be absorbed in the infant’s SI, thus leaving it available for fermentation in the LI.  
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This appears to be due to various reasons from processing to physiology.  Children do not 
produce adult levels of enzymes, which is likely a leading contributor to most starches making it 
to the LI (152-154).  In fact, evidence suggests that biology favors efficiency of digestions as 
some salivary amylase from infant and amylase from the mother (breast-fed) make it to the SI 
(153, 154).  Research suggests children may not reach adult profiles until 12 years of age (155).  
Further, commercial processing techniques such as canning (156) may decrease the digestibility 
by infants.  This is likely since processing is known to affect glycemic index (as indicator of 
absorption) (157, 158) and resistant starch formation would be less susceptible in mildly harsh 
milieu of child gut (49, 159).  Understanding how these factors alter substrate availability to 
survive human digestive mechanisms will be important in understanding which bacteria may be 
able to utilize and flourish from its consumption, ultimately allowing us to better understand how 
food choices will impact on going gut health.    
 Summary 
Collectively, it is apparent that more research is needed to better understand the effects of 
DF on the developing gut of children.  More importantly, changes need to be monitored 
throughout the entire development of the child to begin to understand all of the complex 
interactions that impact health.  There are clear developmental differences of the child, which are 
not the same as in adults.  These differences will be important to determine how optimal dietary 
recommendations, and specifically DF, may impact these metabolic interactions.  Together, the 
microecology and human metabolism, hold potential to provide significant contribution to 
improve our understanding of the relationship between food and health.  Technology has been 
uniquely providing new and better methods to study young children using non-invasive and 
generally mild techniques that allow profiling of health characteristics that may lead to an 
improved snap-shot of health.  Indeed, if we are able to make scientifically sound 
recommendations for children regarding an optimal DF intake, then we must work towards 
consensus on the definition of DF and its subsequent methods of measurement.  Identifying, the 
microbiomes associated with health and identifying mechanisms associated with those outcomes 
will lead to insight on targeted dietary recommendations that will provide flexible and 
scientifically grounded inferences.  
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Chapter 3 - Fiber Fermentation in Children as Measured by Breath 
Hydrogen and Methane 
 Abstract 
Objective:  The objective was to assess the dose of dietary fiber (DF) and the response of breath 
hydrogen, methane, and total hydrogen content relative to Institute of Medicine (IOM) 
recommended intakes. Study Design: Free-living preschool children were fed oat-based cereal 
designed to provide 25%, 50%, and 75% of the IOM’s recommendation for fiber.  Breath 
hydrogen, methane, and total hydrogens (ppm) were measured via breath collection over 
approximately 6 hours.  The design was a counter-balanced crossover. Results: Only four of the 
18 participants were able to comply with the treatment protocol.  Although no significant 
differences were noted in breath measures of fermentation across fiber consumption levels, there 
was a numerical pattern for increasing levels of DF to evolved increased gas production in the 
four compliers.  All children produced hydrogen and methane sometime during the test.  In 
addition, 98% of tests produced breath methane in excess of 1 ppm.  Conclusions: In free-living 
individuals measures of acute fiber fermentation through breath was not sensitive enough over 6 
hours to distinguish a difference in fermentative rate.  Children, parents, and child care centers 
found this approach apparently acceptable.  This study provided a framework into the feasibility 
of studying young children in gentle, non-invasive, and cost-effective manner.      
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 Introduction 
Evidence suggests that children do not consume enough dietary fiber (DF), both in the 
United States [1, 2] and around the world [3, 4] according to current recommendations.  This 
finding is not surprising as most adults do not consume enough DF either, both in the US [1] and 
elsewhere [5, 6].  Consumption of low amounts of DF has been found to be associated with 
conditions including: type II diabetes [7], weight status [8], cholesterol metabolism [9], colonic 
health [10], cancers [1, 11], cardiovascular disease [12], blood pressure [13], and energy intake 
[14].  Children have been hit with similar maladies that adults were traditionally known to 
acquire.  Two conditions of increasing concern in children are obesity [15] and Type II Diabetes 
[16].  Thus, there has been increasing attention at solving these emerging burdens on health 
starting in young children worldwide [17].   
Integrating DF into the diet is recommended for improved overall nutritional quality [18]. 
However, it is also recognized that empirical and mechanistic research regarding implications of 
its consumption are lacking, especially in children [19, 20].  A life-course approach to health 
should be considered, starting with young children [21].  Therefore in children it is important to 
determine the impact that DF has on the ability of a child to flourish and eventually provide a 
base for adulthood.  Fiber has been recommended as a target to fight obesity, consequently 
improving health outcomes [22, 23].  Understanding how much fiber each child needs and the 
mechanisms by which fiber contributes to improving the health of children will help in making 
appropriate, science-based nutritional recommendations.  A major fate of DF in the human body 
is its fermentation by bacteria in the large intestine [24, 25].  Understanding the impact of DF 
fermentation may hold keys to understanding the link between diet and measureable metabolic 
impacts. 
Dietary fiber is not well defined and controversy exists in not only which, but how much 
of each type of DF should be recommended [26].  Dietary fiber has been labeled as “unrealistic” 
to define [27].  In fact, a precise definition is still being debated [28, 29] with no agreed 
consensus even within the Food and Drug Administration (FDA) and National Academy of 
Sciences (NAS) in the United States.  To date, fiber content in food is determined by the AOAC 
approved methods, which makes fiber content dependent on those methods [29].  The 
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discrepancy between physical and functional properties makes the nutritional implications of 
eating DF potentially susceptible to conflicting results. 
All of these factors have contributed to the difficulty in assessing the implications of fiber 
consumption in adults, let alone in children, and the downstream affects.  Measuring the impact 
of DF in-situ is very difficult and few studies have been carried out in humans [30] regarding any 
such attempt.  Thus, proxy measures have been developed in association with DF intake.  Much 
of our knowledge was gained from animal and in-vitro models of fermentation [31, 32] through 
measures of fecal weight [33], fecal energy [34], short chain fatty acids (SCFA) [35], fecal pH, 
and more recently fecal bacteria [36].  Further knowledge of indigestible carbohydrate utilization 
has been limited by its method of study such as: intubation studies [37, 38], ileostomy [39], and 
hydrogen breath test (HBT) analysis [40-42].  Each method has limitations; however, the HBT is 
a better non-invasive, reproducible, and sensitive procedure for assessing carbohydrate [42, 43] 
fermentation in the large intestine.  
The purpose of this research is to gather information regarding the impact of DF in free 
living preschool children by utilizing non-invasive methodologies to assess the fermentation of 
DF.  The objective was to assess the dose of DF and the response of breath hydrogen, methane, 
and total hydrogen content relative to recommended intakes.  The hypothesis was that increased 
DF consumption by children would result in increased hydrogen and methane evolution as 
measured by breath gas evolution. 
 Materials and Methods 
 Participants 
Participants were preschool (3-5 years) children from a university associated childcare 
facility at Kansas State University.  Two classrooms were targeted for recruitment with a total 
population of 30 children.  We were able to acquire informed consent/assents from the parents 
and/or guardians of 22 children attending the facility.  Out of those 22, we were able to obtain 
data on 18, with 14 providing the target of three measurements.  Parents of children were 
questioned regarding the gastrointestinal health of their child for any symptoms of abnormalities 
in gastrointestinal function or known confounders. Exclusion criteria would include the presence 
of clinical constipation, antibiotics use within the last month, inflammatory bowel diseases and 
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any intestinal distress (recent diarrhea).  Inclusion criteria required that children were apparently 
healthy upon entry into the study, age three to five, and consume commercially available cereal.  
In addition, on each testing day, fliers were sent home with parents to fill out to ensure 
conditions upon entry to the study had not changed.  This project was approved by the 
Institutional Review Board of Kansas State University (IRB #6092). 
 Research Design            
The experiment was set-up in a counter balanced cross-over design.  Participants were 
allocated treatments by classroom after signing informed consent/assent to the treatment order.  
The original design structure though was disregarded as children were not able to completely 
comply with the treatment structure.  Treatments consisted of DF obtained from a commercially 
available cereal (Kellogg’s Fiber Plus, Kellogg Sales Co, Battle Creek, MI) at the local grocery 
store.  The cereal was chosen based internal tests of acceptability with children.  In addition, to 
meet childcare food quality and safety guidelines it was critical to provide a sealed product that 
was allergen free.  The product was primarily whole grain oat flour free of major allergens, 
making it ideal for use in this environment.  As most children do not meet recommendations of 
DF intake we wanted to minimize potential negative outcomes and keep consistent with dietary 
advice.  Thus, treatment levels consisted of 25, 50, and 75% of DF intakes as recommended by 
the Institute of Medicine (IOM) with an adequate intake (AI) 14 g/1000 kcal.  Estimated energy 
requirements as documented by IOM’s Dietary Referenced Intakes (DRI’s), were calculated to 
assess AI. 
 Study Protocol 
Parents were provided packets the evening prior to the study test day.  Packets included 
treatment condition (cereal level), breath hydrogen collection apparatus (GaSampler™, 
Quintron, Milwaukee, WI), written instructions for use and a DF informational flier.  Parents 
were verbally instructed on the use of the GaSampler™ kits for collection of baseline breath 
samples.  All children participating in the study were verbally instructed during “instructional 
time” and allowed to practice with the collection method.  We found in most cases the children 
were able to teach parents in the proper method of collection.  This was likely to increase the 
adherence to test protocol and was an intangible source of pride in this study sample group.  In 
addition, parents were instructed and reminded on common DF containing foods and encouraged 
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to limit the consumption of these products for supper or late snack as they are known to 
influence the tests [43].  Parents were given a Kansas State University Research and Extension 
flier designed for parents and families about DF and common DF containing foods to increase 
their ability to adhere to protocol.      
The morning of the tests, children would wake-up according to the typical morning 
routine, brush their teeth and then collect a morning breath sample in the fasted state.  Children 
would then consume cereal with 25%, 50%, or 75% of recommended DF intake.  Parents would 
record the time of consumption, changes in stool habits, antibiotic use, DF consumption the night 
before, and snack consumption the night before. There was also a comments section for 
recording events that may not have been anticipated.  When children reached the child care 
center, baseline samples were collected, with subsequent breath measurements at half-hour 
intervals, with one hour intervals for lunch and recess breaks, and a final measurement occurring 
post-nap.  When children were not able to completely eat all of the provided cereal, the extra was 
returned and weighed to calculate amount of sample consumed.    
Samples were collected at regular intervals up to 7 hours with the GaSampler reusable 
collection bag (Quintron Instrument Co, Milwaukee, WI, QT00841-P).  Breath samples were 
extracted from the GaSampler reusable collection bag with Monoject 35 mL plastic syringe 
(Quintron Instrument Co, Milwaukee, WI, QT-01735-V) fitted with a 1-way plastic stopcock 
(Quintron Instrument Co, Milwaukee, WI, QT01727-V).  A total of 30 mL was extracted from 
the reusable collection bag and injected within two-hours of collection into the BreathTracker SC 
(Quintron Instrument Co, Milwaukee, WI, QT05000-M).  Total H2, CH4, and CO2 were recorded 
for each measure and were normalized according to CO2 of 5.5%.  
Hydrogen and methane values were used to calculate incremental area under the curve 
(iAUC), total hydrogen, total methane, and total H2 atoms.  The lowest value achieved prior to a 
sustained rise in breath hydrogen was defined as the basal hydrogen level [42], which was also 
applied to methane and cumulative H2 ppm.  Cumulative H2 ppm produced is a novel measure 
reported here to reflect total hydrogen gas evolution patterns.  Methane production consumes 4 
mol of hydrogen for 1 mol of methane. This is important because methane production depends 
on hydrogen availability and does not show the rapidly altering production patterns of hydrogen 
and is typically more consistent [44].  This may hide the total amount of carbohydrate being 
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fermented at any given time.  Basal hydrogen level was then used as the baseline for iAUC 
calculation.       
 Anthropometry 
In order to calculate body mass index (BMI), we collected height and weight.  Height 
was measured in cm with a Seca 214 Portable Stadiometer (Seca, Hanover, MD).  Children were 
measure according to standard protocol with four contact points with a horizontal Frankfort 
Plane.  Averages were reported of duplicate measures.  Weights were recorded in kg using a 
Health-O-Meter digital scale (HDL626, Sunbeam Products Inc., New York).  Measures were 
taken in duplicate and reported as the average.  Body mass index was calculated using the 
standard formula .  In addition, because children under the age of 20 are not 
classified under the same criteria as adults [45], BMI percentiles were obtained from the CDC 
growth charts and reported.   
 Statistics 
Graphpad Prism 6 (Graphpad Software, La Jolla, CA) was used to calculate the iAUC for 
hydrogen, methane and total hydrogen ppm produced.  Treatment means for all participants as 
well as high adheres were analyzed by using the Mixed procedure of SAS version 9.2 (SAS 
Institute, Cary, NC).  High adherers were defined as those who were able to complete the test as 
instructed by the protocol.  The MIXED procedure of SAS was first used to assess the null 
hypothesis that level of DF consumption is not associated with hydrogen evolution and total gas 
evolution in a dose-response relationship at significance level of p = 0.05.  Treatment differences 
were analyzed using Excel paired t-tests p = 0.05 (Microsoft Corporation).  The test was also 
repeated for methane evolution and graphical representation of a pattern justified analysis, which 
is sometimes reported as not necessary [42] at a p = 0.05.           
 Results 
Descriptive analysis of children participating in the study can be viewed in Table 1.1.  
Evaluation of BMI placed 4.5%, 81.8%, and 13.6% of children in the underweight, normal 
weight, and overweight, respectively.  These numbers were based of BMI percentile for the most 
recent [45] CDC height and weight charts and current interpretation of percentiles.  Overall, 30 
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children attended the daycare center and 22 participated consented to participate in the DF trial.  
Out of the 22 who were participants in the trial, 14 were able to provide data on three occasions.  
Interestingly, only four were able “adhered as intended”.  “Adhering as intended,” was defined 
as consuming at least 90% of cereal on a particular day assigned and was determined post-hoc.  
This was necessary as we could only offer and encourage children to consume the cereal.     
Admittedly, compliance was only achieved at a relatively low percentage of 20% or an n=4 out 
of 18 participants.  Compliance in the high adherers group of near 100% consumption of DF 
offered, which corresponded to the treatment structure of 25, 50 and 75% DF recommendation.  
Furthermore, compliance with DF consumption relative to the amount offered was 84, 66, and 
46%, with treatments 25, 50, and 75%, respectively.  This corresponded to a compliance with 
treatment structure of 21, 32, 34% for 25, 50, and 75% treatments, respectively (Table 3.2).  
Analysis of dose-response of hydrogen evolution analyzed as iAUC revealed no 
significant relationship with increasing DF consumption (p = 0.48) amongst all participants 
(Figure 3.2).  However, a significant difference (p ≤ 0.05) was observed between individuals for 
gas evolution.  Although not significant, “high adherers” did not show the same between 
individual significance (p = 0.125).  In addition, hydrogen gas evolution due to consumption of 
DF was not found to be significant (p = 0.30) in the “high adherers” group, but numerical 
significance was much closer to the significance required for null hypothesis rejection (p = 0.05) 
(Figure 3.3). 
Analysis of dose-response of methane evolution analyzed as iAUC resulted in no 
significant relationship with increasing DF consumption (p = 0.25) amongst all participants.  
Similar to results obtained with hydrogen evolution, a significant individual effect was found (p 
≤ 0.05).  When the “high adherers” were analyzed, similar results were seen as reported with all 
participants with non-significance due to DF consumption (p = 0.25).  Individuals were still 
significant in methane evolution (p ≤ 0.05). 
Total hydrogen ppm produced as calculated from methane and hydrogen production 
revealed a significant relationship with increasing DF consumption (p ≤ 0.01) amongst all 
participants for individual.  However, remained highly non-significant for DF consumption (p = 
0.59).  When only the high adherers were analyzed all significant differences were removed for 
the individual and the treatment (p = 0.22 and 0.24, respectively).   
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In populations there are individuals who are reported as non-producers of hydrogen gas.  
Typically, they are tested with a known gas producer or fermenter (lactulose) to determine if 
hydrogen gas is produced.  Although, tested as free living individuals in response to cereal DF 
consumption, 100% participants were able to evolve at least one spike of 10 ppm of hydrogen.  
Clinically, of more importance is the measure of methane production.  Methane was produced 
98% of the time, which translates to one occasion.  When viewed as average production of 
methane over time, three children (16%) on 8 occasions (16%) produced less than 1 ppm.  These 
results are interesting given other published studies.  However, these results are the first in free-
living pre-school children with no known health conditions.   
 Discussion 
To our knowledge, evidence of DF fermentation in healthy free-living pre-school 
children has not been reported previously.  The null hypothesis that increasing DF dose does not 
have an increasing response with breath hydrogen and methane evolved was accepted.  This 
study shed light on the feasibility of studying the fermentation of DF in the human large intestine 
and more specifically the developing pre-school child in a gentle, non-invasive method.     
Carbohydrate escaping digestion in the large intestine can be detected in as low as 2-5 g 
[41] and in a dose-dependent manner in tightly controlled experimental settings [46].  Some 
studies have also suggested that gas produced in-vitro showed little distinction between mass of 
sugar fermented [46, 47], however it is logical that the stoichiometry may influence the 
fermentation [48] in regards to total hydrogen produced.  Studies in adults have found that 
consumption of non-digestible carbohydrate leads to an increase in breath fermentation detection 
[49, 50].  In addition, one prior study has found similar results in young children (3-8) who 
consumed different cereal products [51].     
In our study, amongst all the participants, there was a significant individual effect on gas 
evolution.  This agrees with past literature suggesting the detection of gasses is highly variable 
between subjects [42, 52, 53], but also within subject [53, 54].  However, we did not observe 
significant increases due to fiber consumption in either light adherers or high adherers groups. 
Previously, published studies have shown that fiber content the day before may play an 
important role in next day breath excretion [55] and may have contributed to our inability to 
detect a dose-response relationship.  Measurement time was approximately 7 hours for the 
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participants in our study, and 6 hours is considered a minimum, but breath evolution may not 
return to basal values within 14 hours [56].  However, when studying children for this length of 
time has some practical challenges that must be considered.  Due to the fact that our participants 
were free-living subjects, it is likely that other factors played a role in large variation.   
Interestingly, the group labeled “high adherers,” meaning they consumed the DF as 
intended in the protocol did not produce significant results by individual, but treatment variation 
was much closer for total hydrogens to be significant (p = ~0.22), albeit still not significant.  
There is an increasing stair-step trend with increasing DF intake for hydrogen, methane and total 
hydrogens (Figure 3.3).  Furthermore, there were no significant differences in the light adherers 
groups as the iAUC remained relatively constant, despite treatment (Figure 3.2).  This was likely 
due to the fact that the high adherers were not able to comply with the treatment protocol (Table 
3.2).  There was no measured reason to believe that these individuals were different from that of 
the larger population in any descriptive traits.  It is possible to speculate that the variation due to 
individual was marginalized relative to an increased precision in treatment variation, but still at 
relatively high levels.  Nevertheless, the numerical trends noted in this study in combination with 
the reduced p-value with increasing compliance suggest that linear response may exist.      
  All individuals produced at least 1 ppm methane in our study.  There was only one 
occasion when no methane was produced or 2%.  The mean basal methane production was 2.84 
± 2.53 ppm.  The methane results are not surprising for studies that we have conducted in our 
laboratory, but the values are not consistent with previous literature.  Previous research indicates 
that methane is generally produced within a relatively constant percentage of a population [57, 
58].  Traditionally, methane production has been consistent around 34% averaging 15.2 ppm 
[59].  Participants in this study are different than previously reported as 98% of our tests were 
positive for > 1 ppm produced.  Three individuals averaged less than 1 ppm over all time points 
measured.  This still leaves 84% of samples positive for methane production.  One published 
study suggests that ethnicity should be considered [60], it should also be noted that 88% of some 
populations have been noted to produce methane [61].  However, presence in children is more 
variable [44, 62].  Taken together, it is possible that children have a different methane evolution 
patterns than adults.  More research needs to be conducted in children to better determine the 
prevalence to methane producers as it has been linked to health outcomes [63, 64].  Regardless, 
the measurement of methane with translation to total hydrogens produced (Figure 3.5) illustrated 
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slightly different fermentative pattern that could be useful in future studies [43], particularly if 
followed through to baseline [42].    
The concept of non-producers, that is those who do not produce over 10 ppm of hydrogen 
after lactulose load, are also a constant percentage (2-10%) in the population ([60, 61, 65]).  All 
of our participants produced at least 10 ppm.  Low hydrogen evolution is considered to be an 
enhanced utilization of hydrogen in these individuals [48, 66, 67].  In young children, such as 
those of pre-school age the development of an adult profile is desired.  This has been considered 
a critical stage in gut colonization just after weaning [68].  Measures in this age group could be 
highly variable based on the early colonization succession.  However, our results did not differ 
from those in the population suggesting that pre-school age children should have no inhibition of 
hydrogen production.  These results suggest that children as young as three are capable of 
producing hydrogen and thus, have another measure from which to non-invasively study this age 
group.              
This study was limited by the small sample size of participants who completed the study 
as intended.  Post-hoc sample size analysis revealed that increasing the sample size to 30 
participants would provide 0.753 power to detect significant differences in a similarly conducted 
study.  In addition, due to the nature of this study in free-living individuals many factors of 
control was not implemented to avoid potential confounders.  Studies with children should 
consider the development of the child in the planning of the experimental design.  Children have 
three major categories of development to keep in mind that could potentially influence resultant 
individual variability.  In our discussions, children have “commonalities,” interindividual 
variability, and intraindividual variability [69].  A study should be designed with these 
differences in mind in order to get a precise measure of individual variation.  In future studies it 
would be important to control for, and provide the previous nights’ dinner.  In addition, the test 
day’s snacks and meals should also be controlled for size and food types, which are in 
accordance with low fermentation patterns.  This should be coupled with an extended period of 
monitoring.  Due to the location of the study (child care center) we were restricted in the amount 
of control we could provide.  This was important to reduce the burden on parents, children, and 
the child care center and accommodate as “normal” of conditions as possible.  Future studies 
should be conducted to determine the time needed to differentiate DF fermentative patterns in 
both children and adults.  Also, more studies need to be conducted to determine the length and 
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number of intervals that provide more consistent estimate of changes in fermentative pattern in 
response to DF.  
 Summary 
Nevertheless, this trial offered some positive outcomes; we found the breath test to be 
apparently acceptable to preschool children, parents and teachers.  In most cases it was an 
important learning experience and could be integrated with classroom curriculum.  There are 
concerns of safety from parents and teachers when dealing with children; however, we felt the 
interaction was beneficial for both groups and not detrimental through observation and personal 
communication, although this was not quantitated.  When working with children it is important 
to invest the time getting familiar with all parties involved and developing clear methods and 
goals.  We did not see significant difference in acute breath hydrogen, methane or total hydrogen 
breath evolution response to dietary fiber dose.  This was a simple non-invasive measure that 
provided innovative data to a group that has not been traditionally studied, potentially due the 
many difficulties associated with young child research.  Standard methodology for carbohydrate 
fermentation and interpretation of metabolic outcomes does not exist, but does have potential for 
helping to characterize fermentation and provide insight into gut health.  Our results should be 
taken with caution as they are the first of their kind, but do highlight the ability to study pre-
school children in an apparently feasible manner.    
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Table 3.1. Population Characteristics with Recommended Energy and Dietary Fiber 
Intakes 
              
 
N 
Age 
 (SD) y Ht (SD) m 
Wt  
(SD) kg 
Energy Needed 
(SD) kcal/day 
IOM Fiber Rec 
(SD) g/day 
Age + 5 Fiber 
Rec (SD) 
g/day 
Boys 9 4.3 (0.7) 1.07 (0.08) 18.7(3.2) 1501 (143)*# 21.0 (1.2)*# 9.3 (0.7)~ 
Girls 9 4.2 (0.8) 1.05 (0.06) 16.9 (2.1) 1469 (89)*# 20.6  (1.2)*# 9.2 (0.8)~ 
Overall 18 4.3 (0.7) 1.06 (0.07) 17.8 (2.8) 1486 (117)*# 20.8 (1.6)*# 9.3 (0.7)~ 
        * IOM 2006 Food and Nutrient Guidelines 
   # PA level of low active assumed 
    
~ 
Age + 5 
Guideline 
      
 
 
Table 3.2. Participant Compliance by Group 
  
Average Fiber 
Consumption (g) 
 
Fiber Consumption 
(%) 
 
Percentage of 
Recommended 
Intake 
All Participants (n=18) 
   25% 4.5 ± 1.2 87.9 ± 20.8 22 ± 5.3* 
50% 7.4 ± 3.7 73.2 ± 35.5 35.8 ± 17.5* 
75% 9.3 ± 5.2 59.2 ± 31.5 44.5 ± 23.9* 
High Adherers (n=4) 
   25% 5.3 ± 0.4 100 ± 0.0 25.3  ± 0.3* 
50% 10.4 ± 0.4 97.9 ± 4.2 49.4  ± 2.5* 
75% 16.0 ± 1.0 100 ± 0.0 75.7  ± 1.4* 
Light Adherers (n=14) 
   25% 4.3 ± 1.3 84.2 ± 22.6 21.0 ± 5.7* 
50% 6.5 ± 3.8 65.6 ± 37.6 31.7 ± 18.1* 
75% 7.0 ± 3.8 45.6 ± 23.4 34.1 ± 17.5* 
 
*As recommended by IOM at 14 g/1000 kcal. 
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Figure 3.1. Participant Flow Diagram 
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Figure 3.2. iAUC for Hydrogen, Methane, and Cumulative Hydrogen Evolution in Light 
Adherers 
 
 
 
Figure 3.3 iAUC for Hydrogen, Methane, and Total Hydrogen Evolution in Light Adherers 
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Figure 3.4 Hydrogen (ppm) Breath Evolution over Time in High Adherers 
 
 
Figure 3.5 Methane (ppm) Breath Evolution over Time in High Adherers 
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Figure 3.6 Calculated Total Hydrogen (ppm) Breath Evolutin over Time in High Adherers 
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Chapter 4 - Metabolic Effects of Fiber Consumption Between Adults 
and Children 
 Abstract 
 
Background:  Children consume dietary fiber (DF) at less than half the current Institute 
of Medicine (IOM) recommendations, and guidelines for children are extrapolated from adult 
studies.  Little evidence exists in children to assess the impact of fiber fermentation in the gut.   
Objective:  The objective of this research was to investigate the metabolic consequences of DF 
consumption in children and adults and determine if children and adults utilize DF similarly. 
Design:  Children and their parents were fed 10 g of fiber daily for six days a week, over a three 
week period.  Baseline and post measures of breath hydrogen, methane, oro-cecal transit time, 
time to peak, fecal pH, and fecal short chain fatty acids were taken.  Weekly measures of bowel 
habit and symptoms diaries were also taken.  The design was a randomized block with a split 
plot for time.  Results:  Fecal propionic acid increased (p<0.05) from 106.7 to 127.5 µmol 
following DF consumption.  There was also an interaction (p=0.05) between time and age for 
butyric acid.  Bloating decreased (p=0.05) from week one to week two.  Conclusions:  Dietary 
fiber consumption as an increase of 10 g/day over three weeks is well-tolerated in this form, with 
no disturbances in bowel habit in either children or adults.  Alternatively, there were no 
improved bowel habit measures with increased DF consumption.  This study yields evidence that 
adults and children may process breath fermentation measures similarly.  Current methodology 
allows for apparently feasible study of young children in a non-invasive and cost-effective 
manner, but the current measures did not show distinct child and adult differences.   
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 Introduction 
Dietary Fiber (DF) is an indigestible food which contains a unique mixture of bioactive 
compounds encompassing vitamins, minerals, phytochemicals, antioxidants, and resistant 
starches (1).  Epidemiological and clinical evidence on DF and whole grain indicates that 
consumption is inversely associated with obesity (2), type-two diabetes (3), cancers (4) and 
cardiovascular disease (5).  Increased intake of DF has been associated with positive health 
outcomes, suggesting that a lack of consumption may decrease the potential health benefits.  In 
addition, DF is metabolically active in regards to large bowel health, and is associated with 
outcomes involving constipation and colonic disease (6).; however, due to the observational 
nature of these studies, conclusive evidence is needed to provide insight on fiber’s health 
benefits (7).  In fact, it has been suggested that all of the health benefits associated with DF 
sources such as whole grains, could be derived from fermentation of DF by the bacteria present 
in the large intestine (8, 9). 
  Part of the inconsistent results reported with DF consumption and its health implications 
can be attributed to its ambiguity in definition and quantification.  In a strict technical sense, DF 
has been labeled as “unrealistic” to define (10).  A specific definition is still the source of debate 
today (11, 12) with no agreed consensus, even within leading health organizations in the United 
States.  Fiber is only measured by AOAC approved methods and thus, fiber content is dependent 
on those methods (12).  These large conceptual issues have contributed to the difficulty in 
delineating specific effects of DF in adults, let alone in children.  Current recommendations 
suggest that children and adults require the same amount of fiber relative to total energy 
consumption and evidence is lacking to confirm or refute this idea (13).      
Measuring the impact of fiber in-situ is very difficult and only a few studies have been carried 
out in humans (14).  Moreover, much of the current knowledge regarding DF implications on 
metabolism is due to animal and in-vitro models of fermentation (15, 16).  In humans, limited 
evidence has been provided through the use of ileostomy and intubation studies (17-19), however 
these should be considered with their inherent limitations (17).  Thus, it is important when 
investigating mechanisms in humans, especially children, that non-invasive and gentle measures 
are utilized.  Non-invasive metabolic markers that have been associated with health outcomes 
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exist and can help to provide insight into DF impacts in the human gut.  These measures include: 
fecal weight (20), fecal energy (21), short chain fatty acids (SCFA) (22), fecal pH, breath 
hydrogen testing (17, 18, 23), and recently genetic identification of gut microflora (24, 25).  The 
importance of microbial fermentation may not be fully understood and has been targeted as the 
sole benefit of whole grain and DF consumption (8, 26).   
Clinical evidence is needed to verify observations regarding DF consumption and to 
determine any metabolic impacts in the gut.  The objective of this research was to investigate the 
metabolic consequences of DF consumption in children and adults and determine if children and 
adults utilize DF similarly.  The hypothesis was increasing DF consumption by 10 g/day in 
children and adults would increase breath and fecal measures of fermentation.  The null 
hypothesis was that children and adults would show no differences with respect to maturity or 
time over these measures. 
          Materials and Methods 
 Participants 
Parents and children were recruited from the Kansas State University (Manhattan, KS) 
community through e-mail list-serves and fliers.  Fliers were attached to e-mails or handed out at 
local pre-schools, childcare centers, and through University announcements.  Interested parties 
met with researchers to review complete protocols with both the parents and the children before 
signing consent/assent forms.  Exclusion criteria were treatment with antibiotic within one month 
of the study, vegan, a history of gastrointestinal disorder, and dislike of cereal products.  Eight 
parent/child combinations consented to participation in the study, with a total participation of 16 
individuals.  One pair was excluded from analysis for failure to meet study expectations.  This 
study was approved by the Institutional Review Board of Kansas State University (IRB #6091).   
 Test Sample 
Participants were asked to consume a commercially available cereal product (Kellogg’s 
Fiber Plus, Cinnamon Oat Crunch, Kellogg’s) that contains approximately 1 gram of fiber as 
measured by TDF (Nutritional Facts Label) for every 3.5 g of cereal.  The cereal is primarily 
whole grain oat flour with soluble corn fiber and corn bran as the main ingredients.  Providing 
fiber from this source allowed a feasible and appealing method for fiber delivery to young 
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children that was also suitable for adults.  Participants were provided 10 g TDF or 35.5 grams of 
cereal and asked to consume the amount provided each day and avoid carry-over or “doubling 
up.” 
 Study Design 
The study was designed to investigate the change in colonic microflora fermentation over 
three weeks between adults and children with increased DF intake of 10 g/day, providing near 
the IOM recommended dose of fiber.  Three weeks has been shown to be sufficient for 
measuring fermentation changes (25, 27, 28).  Parents and children provided baseline 
measurements and were asked to consume the cereal for twenty-one days.  Participants were 
allowed one “free day” out of every seven days to help ensure compliance.  In addition, 
participants completed weekly symptom diaries each week as self-reported bowel movement, 
discomfort, flatulence, bloating, stool consistency, and overall general well-being.  Responses 
were marked on a scale of 1 to 5 (1 being optimal/normal and 5 worst/abnormal).   
 Study Variables 
Measurements were taken at the Foods and Nutrition Laboratory at Kansas State 
University.  Participants were measured at baseline for height and weight, in addition to three 
day diet record (3DR) to record food intake.  Measurements collected at baseline and post fiber 
treatment were oro-cecal transit time (OCTT), fecal short chain fatty acids (SCFA), fecal pH, 
and total hydrogen/methane production at 4 hours post lactulose load after an overnight fast.  
Weight was assessed using Ohaus ES 200L/Series scale (Ohaus, Corporation, Parsippany, NJ) 
with measures occurring in duplicate and a third measurement was taken if readings were more 
than 0.1 kg apart.  Height was assessed via a Seca wall-mounted stadiometer.  Measures were 
taken in duplicate and were repeated if they were more than 5 mm apart.  Averages were 
reported for both height and weight with standard deviation and were used to calculate their body 
mass index (BMI).   
 Food Record 
Participants were instructed to report their food intake utilizing the 3DR.  Intakes were 
only recorded at baseline to represent typical intake at the time of the study and assumed to be 
relatively similar throughout the duration of the study period.  Parents were instructed to record 
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the intake of two weekdays and one weekend day for both themselves and their children.  They 
were encouraged to choose consecutive days, but also choose days that would be the most 
representative of habitual intake.  Proper completion of the 3DR was orally discussed with all 
parents.  In addition, written instructions detailing examples of the proper information and way 
to record foods were given to each parent.  An example diet record was provided as an example 
of details to record about foods.   Participants were encouraged to e-mail and call at any time if 
questions arose.  These assessments were primarily used to determine the total macronutrient 
make-up, caloric intake, and DF consumption of each participant.    
 
Breath Hydrogen Test 
Oro-cecal transit time, total hydrogen (ppm), total methane (ppm), and total H
+
 (ppm) 
were measured via the breath hydrogen test (BHT) over 4 hours at 0, 30 45, 60, 75, 90, 105, 120 
minutes and every half hour up to four hours.  Lactulose was given based on its ability to resist 
small intestinal digestion, thereby providing a reliable and repeatable source of fermentable 
substrate (23, 28, 29).  Participants were given 0.25 g lactulose / kg body weight, up to a max 
dose of 10g.  We felt it was important, especially in children to provide a size based approach to 
dosing in order to truly evaluate fermentative capacity.  To our knowledge only one other study 
has provided evidence for this size-based approach and was further evidence for our 
methodology (30).  Determination for OCTT was determined as the first time marked by three 
consecutive rises in breath hydrogen that cumulatively are ≥ 10 ppm, or two consecutive rises 
where the cumulative is ≥ 20 ppm total (31, 32). 
Breath samples were extracted from the GaSampler reusable collection bag (Quintron 
Instrument Co, Milwaukee, WI, QT00841-P) with Monoject 35 mL plastic syringe (Quintron 
Instrument Co, Milwaukee, WI, QT-01735-V) fitted with a 1-way plastic stopcock (Quintron 
Instrument Co, Milwaukee, WI, QT01727-V).  A total of 30 mL was extracted from the reusable 
collection bag and injected within two-hours of collection into the BreathTracker SC (Quintron 
Instrument Co, Milwaukee, WI, QT05000-M).  Participants received their own collection bags 
and were the only individuals to use those bags throughout the duration of the study.  Total H2, 
CH4, and CO2 were recorded for each measure and were normalized according to CO2 of 5.5%, 
which is a valid way of correcting for dead space and atmospheric contamination (40).  To 
ensure samples were not diluted, dead-space air was eliminated by calibrated air discard sac.  
60 
 
This allowed for the disposal of up to 750 ml of dead space air.  Once the blow-off sac was full, 
air was automatically diverted through a one-way valve for collection of alveolar air or end-
expiratory air (23).       
During the test, participants came in after a 12-hour fast.  Participants were instructed to 
consume a low fiber meal and were presented alternatives when necessary.  The same meal was 
consumed the night before each test.  When the previous condition was not possible, a low fiber 
meal was consumed in its place.  Participants were also advised to consume light meals with no 
snacking after supper and no alcohol.  During the test, participants were to be awake, refrain 
from caffeine, smoking and exercise.  Due to the age of the participants, easily digestible snacks 
were provided in less than 200 calories to prevent passing of carbohydrate beyond the small 
intestine.  The same snack was consumed in the pre and post trial to ensure both test were treated 
equally.  Hydrogen and methane values were used to calculate incremental area under the curve 
(iAUC), hydrogen, total methane, and total H2 ppm.  The lowest value achieved prior to a 
sustained rise in breath hydrogen was defined as the basal hydrogen level (23), which was also 
applied to methane and cumulative H2 atoms.  Basal hydrogen level was then used as the 
baseline for iAUC calculation. 
 Bowel Habits/Symptoms Diaries 
Symptom diaries were self-reported by participants and parents verbally explained the 
survey for children and reported their responses.  Symptoms/habits measured included bowel 
movement, discomfort, flatulence, bloating, stool consistency and general well-being on a scale 
from 1 to 5 (1 being optimal/normal and 5 worst/abnormal) as previously reported (25). 
 Stool Collection and Preparation 
 S Stool was collected within 3 days prior to the first study day and immediately prior to 
study completion.  Stool was received within one hour of voiding and processed within two 
hours.  If samples were not immediately prepared and stored, they were placed in 7°C until 
processed within the two-hour time limit.  Samples were homogenized manually with a 
Sterileware (Bel-Art Products) sampling knife.  In a 50 mL Corning Centrifuge Tube, 27 ml of 
Phosphate Buffered Saline (PBS) were added.  To the PBS, 3 g of stool were added, and the 
mixture was homogenized via vortex for approximately 30 seconds to one minute.  Cryovials 
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(Fisherbrand, 2ml) were filled with approximately 1.5 ml homogenized stool/PBS slurry.  
Samples were stored in -80°C until further processing.     
 Fecal pH 
Fresh fecal samples were packaged with sterileware
®
 plastic knife (Bel-Art Products) in 
bulk Nalgene
®
 Specimen Collection Cup 15 mL Cryogenic Screw-top vials (Thermo Scientific).  
Samples were subsequently thawed and two grams were mixed in a 1:5 dilution with distilled 
deionized (DD) water and homogenized for pH (Accumet pH Meter 25).  Measurements were 
reported as average of triplicate repeated measures.   
 Fecal SCFA 
Fecal SCFA samples were diluted in a 1:5 w/v with double distilled water and 
homogenized and prepared according to previous works (22).  Briefly, samples were 
homogenized for 3 min and adjusted to pH 2-3 with 5 M HCL, and kept at room temperature for 
10 min with gentle agitation.  Modifications to match equipment include placing the homogenate 
in a clean polypropylene tube and centrifuged for 10 min at 3,500 rpm.  Supernatant was then 
transferred to 2.0 ml microcentrifuge vials and centrifuged for 10 min at 8,000 x g.  The clear 
supernatant was then transferred and spiked with 2-ethybutyric acid as an internal standard.  The 
final concentration of 1mM and 1 µL was injected for analysis.  Standard stock solutions were 
prepared with aqueous concentration of 400mM for acetic acid, propionic, and butyric acid.  
Stock solutions were stored at -20°C.   
 Chromatographic Conditions 
Analysis was carried out using Agilent 6890 GC, equipped with a flame ionization 
detector (Agilent, USA) and PALcombi-xt (LEAP, Lake Elmo, MN) autosampler.  The column 
was a Nukol
TM
 FUSED SILICA Capillary Column (SUPELCO, Bellefonte, PA, USA) with 
dimensions of 30 m x 0.53 mm i.d. coated with 0.50 µm film thickness.  Methods used have been 
previously described (22), but nitrogen was replaced with helium as the make-up gas at a total of 
20 mL/min.  Data recording and anaylsis was carried out with HP ChemStation Plus software 
(A.10.02, Agilent). 
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 Statistical Analysis 
The design was a randomized block design with a split-plot.  The split-plot was time and 
the whole plot was age.  The blocking factor was pair or family, which consisted of one parent 
and one child.  Results for all measures, except bowel habits/symptoms diaries, were analyzed 
with the MIXED procedure in SAS 9.2 (SAS Institute Cary, NC) with a significance of p = 0.05.  
Measures for the bowel habits/symptoms diaries were analyzed as repeated measures for time 
(pre, middle, post) in the MIXED procedure in SAS 9.2 to a p = 0.05.  Means, ranges, and 
standard deviations were reported for descriptive statistics.     
 Results 
 Population Characteristics 
A summary of baseline characteristics for children and adults used in this study can be 
found in Table 1.1.  Children ranged in age from 3.9 to 7.9 y with an average age of 5.4 y.  The 
BMI for children ranged from 14.5 to 19.5 with an average of 16.4.  Energy intake in children 
was 1312.0 ± 194.0 kcal/day, Estimated Energy Requirement (EER) was 1561.0 ± 77.2 kcal/day, 
DF intake was 9.9 ± 2.3 g/day, and the AI for DF intake was 21.9 ± 1.1 g/day.  Adults ranged in 
age from 33.2 to 49.8 y with an average age of 38.8 y.  Adults had a BMI range from 19.7 to 
31.4 with an average of 23.5.  Energy intake in adults was 2067.0 ± 106.0 kcal/day, the EER was 
2446.1 ± 487.3 kcal/day, DF intake was 20.5 ± 7.3 g/day, and the AI for DF was 34.3 ± 6.8 g/day 
 Bowel Function and Intestinal Symptoms 
Data for bowel symptoms and intestinal function are present in Table 1.2.  For bloating 
there was a main effect for time with bloating being higher (p < 0.05) during week one than 
week two.  There was a trend (p = 0.06) for flatulence to be affected over time with flatulence 
being higher during week 1 and 2 than week 3.  No other differences were noted for bowel 
function and intestinal symptoms.   
 Fecal Short Chain Fatty Acids and pH 
 Fecal short chain fatty acid and pH main effects are presented in Table 1.3.  There was a 
main effect (p <  0.05) for time propionic acid to increase ( p < 0.05) from pre to post 
measurement following dietary fiber consumption.   No differences were seen for acetic acid or 
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butyric acid due to time or age.  However, there was an age trend (p = 0.08) for acetic acid with 
children possessing numerically higher levels of acetic acid than adults.  No differences were 
observed for pH due to time or age.  There was an age by time interaction (p < 0.05) for butyric 
acid.  Adults post DF consumption and children pre DF consumption had lower (p < 0.05) 
butyric acid levels than children post DF consumption (Table 1.5).   
 Breath Fermentation  
 There were no differences (p = 0.05) in breath fermentation tests pre DF to post DF 
consumption, and there were no significant differences in breath fermentation test between adults 
and children.   However, there was a trend (p = 0.0565) for an age by time interaction for fasting 
breath hydrogen.  Adults pre DF consumption had a lower (p = 0.0565) fasting breath hydrogen 
than adults post DF consumption and children in both pre and post DF consumption (Table 1.5).   
 Discussion 
 The IOM reports the average DF consumption in the United States to be approximately 
15g/day (13).  The adults in our study averaged approximately 5 g more per day than the IOM 
reported average. Initial reports of DF consumption in children were around 12 g/day (33, 34) in 
older children (>10 y) and approximately 11 g/day (35) in pre-school children (3-5 y).  Using 
data from nationally representative surveys, such as the Continuing Survey of Food Intakes for 
Individuals (CSFII) and National Health and Nutrition Examination Survey (NHANES), 
Williams (36) put together a table which shows DF consumption over the last 40 years around 9 
g/day for young children (< 3 y) and about 11 g/day when including older children (3-7 y) (37) 
which has also been recently confirmed in this age group (37).  In the present study, children 
(range 3-7 years old) consumed 9.9 ± 2.2 g/day, which is about on par with past studies.  
Consumption of 10 g/day extra DF as provided in this study should have put both adults and 
children near the IOM recommendation for DF intake.  However, it should be noted that we did 
not measure overall DF at the end of the study only at baseline.  Participants consumed 10 g/day 
of DF as provided and was assumed to be additional intake.      
 In Chinese children (3-7 years old), 10 g/day has been suggested as a “cut-off” amount 
for amelioration of constipation (38).  Improvement in bowel habit has been observed with 
increasing fiber intake from 11 g/day to ~17 g/day in children consuming a fiber snack.  The 
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addition of 5 g/day of glucomannan in constipated children increased parent rated improvement 
in “feeling better” than when not on fiber treatment (39).  There was no change with the increase 
of 10 g/day in bowel movements/habits as measured in this study.  While there was no 
improvement there were also no negative outcomes associated with this measure.        
Dietary fiber was added to diets at a density of 1 g fiber per 3.5 grams cereal, which 
equates to 35 grams of cereal or approximately ¾ of a cup (a recommended serving).  The cereal 
provides about 3.44 kcals/g in energy or ~12 kcals/g of energy of fiber.  This contrasts the less 
dense and current recommendation of 14 g/1000 kcals or 71.4 kcals/g energy per g of fiber.  
Participants in this study likely fell short of recommendations with a relatively dense supplement 
in an apparently agreeable form.   These are important numbers to consider as optimistic 
estimations of fiber consumption in our study would reveal 19.9 g/day in children, and 34 g/day 
in adults.  It is possible that increased fiber consumption through high DF supplementation in the 
form of a commercial cereal product contributed to overall dietary intake increases.   However, it 
is also possible that this relatively small amount of cereal displaced DF throughout the rest of the 
day.   This does not seem likely that all DF could have been replaced and indeed DF was 
increased throughout the trial.  Providing DF in this dense form in suggest that supplementation 
could be important to meeting DF guidelines.  Moreover, this also sheds light into the practical 
implications of consuming the IOM recommended amount by traditional food alone, especially 
in regards to children in this age group.     
Functional differences have been noted between healthy and non-healthy populations, but 
are not well understood.  Furthermore, studies have evaluated the relationship of DF 
consumption and its changes with development of functional constipation.  This is important 
because constipated children may be consuming less fiber for other reasons (i.e. stomach pain 
from compaction, other organic nature) than children who are healthy and fiber is less likely to 
be uncomfortable to consume.  In our study, there were no changes in response to an extra 10 
g/day of fiber regarding bowel habit and intestinal health, except bloating between week 1 and 
week 2.  Bloating significantly decreased from 1.50 to 1.07 between week 1 and 2, suggesting 
that by week three participants were able to adapt to increased DF as no differences were noted.  
In addition, since general well-being or discomfort remained unchanged, this likely did not cause 
significant distress to the participants. There was only one verbalized or communicated 
discomfort reported in reference to cereal consumption, which was increased flatulence, which 
65 
 
can be only be classified as a trend in this study and warrants further attention.  Indeed, 
discomfort due to flatulence may be of increased importance that was not conclusively detected 
in this study.  In patients with carbohydrate malabsorptive disorders, the rapid fermentation by 
the gut microbiota often leads to discomfort (29).  However, this amount of fiber did not seem to 
impart any major discomfort that affected the participans well-being.       
Fiber is known to affect laxation as increased intake has been associated with increased 
bowel movements (1, 39, 40).  However, data for the present study did not provide any 
measureable difference that would contribute to this observation.  However, direct measures of 
stool output or any other objective measure to confirm the self-reported measures were not 
assessed in the present study.  The effects of fiber may not be fully understood and may be 
different between healthy and children with abnormal GI function.  In fact, medical doctors are 
cautious to prescribe fiber during functional constipation due to the complex nature of the 
diagnosis and the inconclusive evidence presented (41).  Further evidence has shown that the 
intestinal transit may be a more localized problem leading to constipation than DF consumption 
and DF may have a longer transit time through the left colon in those with constipation (42).   
Additionally, it is known that children who have developed functional constipation have 
abnormal sensitivity of the sigmoid colon (43). In order to determine the interaction of fiber in 
preventing, treating or other roles it needs to be determine if these differences are a biological 
determinant of abnormal bowel habits or if abnormal food habits contribute to this development.  
More evidence is needed to fully understand the interactions of DF intake and the large intestinal 
response. 
There is major emphasis on understanding the role of microbiota in the large intestine and 
the interactions that occur between the two (44). Bacteria in the large intestine ferment DF when 
it reaches the large intestine or utilizable substrate that reaches the colon (45).  Major microbial 
fermentation by-products include: hydrogen, methane, carbon dioxide, and short chain fatty 
acids.  These microbial metabolites have been linked to a host of health outcomes with 
technology rapidly allowing us insight into how the specific bacteria (1) and substrate are 
interacting to yield measurable outcomes which can be related to health (46).  We did not see any 
significant differences between adults or children in SCFA in response to 10 g/day DF 
consumption.  In this study, fecal propionic acid was the only SCFA to change in response to DF 
consumption over the three week time period.  Increases in propionic acid have been reported in 
66 
 
other studies (34) over time in response to DF supplementation.  However, other studies have 
reported no changes in SCFA due to changes in DF consumption (25).  
Although not statistically significant, butyric acid showed a large numerical increase, 
accompanied with a large standard deviation.  It has been previously reported that fecal SCFA 
seem to be highly dependent on the individual (47).  Also, a recent study evaluating gut 
microbiota and fecal SCFA found that propionate was associated with overweight and obese 
individuals (48).  In the present study, the men’s average BMI was approximately 26 kg/m2.  
More research should be conducted to verify this association, but perhaps the participants that 
were overweight contributed to the higher levels of propionate acid. Many factors influence 
SCFA production such as flow rate of digesta, microflora composition and intrainteraction, and 
total substrate, thus these variables need to be studied in these populations to understand if there 
are environmental factors mediating this result.  In the present study, inherent biological 
variation in the sample population could have led to the large variation and potentially this 
variation could be overcome with larger sampling.  Large biological differences in individuals 
could be driving these differences, as there are many factors influencing the fecal outputs 
including, colonocyte absorption, pH, microflora, and diet.  The present study was designed to 
observe effects relative to age and over time, which were only significant for propionic acid.  
This suggests that indeed parents and children may respond the same to fecal outputs of SCFA 
due to DF consumption.            
In addition, there was a significant interaction, where butyric acid in post DF 
consumption of children was increased above those of adults post DF treatment.  The major 
component of this commercial cereal fiber was whole grain oat flour.  Addition of oat fiber, 
specifically beta-glucan, has been associated with lower cholesterol in both adults and children.  
In addition, it is the only fiber to be an approved health claim with oats.  With fermentation of 
RS and oat fibers, butyrate has been found to be produced in greater amounts in-vitro (59) and 
in-vivo (47).  This is not surprising as the role of butyrate as a source of fuel for the colonocytes 
is well documented (1, 49).  Child profiles of gut microbiota reach those similar to adults at 
various rates and depend on many variables starting in infancy (50), however, similarities are 
seen after weaning (51).  As the same amount of DF was provided to both adults and children in 
the present study, it is possible the butyrate remaining for fecal measurement remained due to a 
relatively larger load, which the child’s colonocytes were not able to fully utilize.  All SCFAs 
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seem to be rapidly absorbed, consumed or utilized in first-pass metabolism.  Perhaps, propionic 
and acetic acids were able to be utilized more completely.   However, the difficulty of 
understanding the full scope of metabolic fates of fecal SCFA has been discussed before (52).  
More research is needed to determine if this interaction is consistent, and if so provides evidence 
that adults and children may have different uptake capacities, as this cannot be determined from 
fecal SCFA output.     
Fecal pH has been linked to many health outcomes.  In our study there were no 
significant differences between children and parents or pre and post DF consumption.  
Numerically, there was a separation between pre and post DF consumption.  Post fiber 
consumption resulted in a mean pH of 7.26 ± 0.14 versus 7.03 ± 0.14 (p = 0.14).  A reduction in 
colonic pH would coincide with increased SCFA production and fermentative rate.  A significant 
difference would help indicate that fecal SCFA are cumulatively increasing and yield some 
insight to levels required for colonic absorptive capacity being reached.  As increasing 
fermentation would increase SCFA, they would likely be subsequently absorbed.  This 
absorption is likely traded with HCO3
-
, which would help buffer colonic pH.  Thus, it would 
make sense that absorptive capacity would be reached with increasing SCFA production.  At that 
point, pH would lower and fermentative reactions would start to slow as pH will start to inhibit 
some metabolic enzymes for the microflora.  In order for pH to remain measurably lower it 
would seem logical that the left colon is less efficient at absorbing SCFA or once a potential 
absorptive capacity is hit the microflora are well adapted to resume fermentation at the slightest 
increase in pH as each enzyme is suited.  No significant difference in pH suggests that parents 
and children may not have differences in pH and instead are set by environmental and 
biologically differences as opposed to developmental differences.     
 The gut is a continuous reaction of changing inputs and outputs.  Decreasing colonic pH 
from 6.5 to 5.5 has been shown to restrict growth (53) of certain species and promote others.  
This is thought to be primarily driven through SCFA synthesis.  In obese rats, increased energy 
intake was found to decrease colonic pH (53, 54).  Increasing SCFA, such as propionate as in the 
present study, should decrease pH.  This lends credence that increased cecal load, not obesity 
itself, as a cause of decreased fecal pH.  However, this would still have important ramifications if 
an autochronous microflora exists and we can identify an indigenous microbiome.  This also 
suggests evidence that adjusting nutrient intake and substrate (nutrition) may have significant 
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public health implications.  In our study, energy intake was relatively low compared to 
recommended intake, as well as fiber.  Yet, there was no significant change and overflow of non-
digested nutrients into the colon would not seem to be a problem in this case. Indeed, more 
research is necessary as limited evidence exists and there is likely a large genetic component 
with each individual.     
   Many studies have tried to look at the significance of breath hydrogen as a marker of 
carbohydrate fermentation.  Few studies have investigated the fermentation of indigestible 
carbohydrates in healthy individuals (55, 56).  Although breath fermentation has been found to 
be limited in the ability to quantify exact amounts of carbohydrate fermented (17, 23); it has 
been found to be an effective relative marker of fermentation (23).  In addition, increasing 
fermentation has been found to be reproducible and repeatable (23).  Load of substrate has been 
found to be proportional to the output of gasses in the breath (57, 58).  We did not observe any 
significant increase in capacity to handle lactulose, an easily fermentatable sugar, in our study 
with hydrogen, methane, total hydrogen produced, or OCTT.  This is similar to other studies, 
looking at similar outcomes (27), but the design of this particular study restricted the present 
study to four hours of sampling, which may have limited discrimination between particular 
fermentation patterns.   
A trend in fasting hydrogen values of adults after DF consumption was observed, which 
was not present in children.  This may provide evidence to the hypothesis that children may 
handle the same fermentative load differently than adults, as they were able to remain stable with 
fasting concentrations.  However, it does seem plausible that the microbiome of the large 
intestine of adults is more fully capable of fermenting the available fuel, because a larger 
diversityis typically found (51).  Thus, in children residual DF may be escaping fermentation 
(59).  This is likely as children are known to incompletely utilize easily fermentable starch (60) 
and would have more difficulty utilizing a more chemically protected fermentative substrate such 
as oat fiber.   
 This study was exploratory in nature and its relatively small sample size limits 
generalizability or representativeness, in addition to statistical power.  In addition, this study was 
limited by having few documented studies available to help guide the research methods.  
Although previously published, the bowel habits/symptoms diaries should be investigated for 
validity.  Alternatively, this was the first study to report metabolic outcomes in children and 
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adults regarding three weeks of DF consumption.  The design of this study allowed for statistical 
control of uncontrollable environmental factors within familial pair.  This study also provides 
insight to understand  the use of non-invasive metabolic markers of health in children that can be 
used to improve understanding of DF implications to gut health. 
 Conclusions 
 This study provides novel evidence of metabolic markers related to DF consumption in 
children and utilized gentle, relatively rapid, non-invasive measures to characterize the impacts 
of DF on the child gut.  Adding 10 g/day of DF in commercial oat cereal to the participants’ diet 
had no positive or negative bowel habit/intestinal symptoms over three weeks.  Free-living adults 
and their children did not show significant differences in selected markers of DF fermentation 
iAUC’s, or fecal SCFA’s (acetate and butyric) and pH.  The presence of interactions of DF with 
butyrate response and a trend for acetic acids warrants further study to determine if these 
differences are repeatable and perhaps explain biological differences between adults and 
children.  A larger study of these variables is warranted, especially between adults and children 
to understand potential genetic and environmental variation. This study provided evidence that 
children and adults in general do not handle DF differently relative to the variables measured.  
However, there were several trends, both statistical (0.05 > p < 0.15) and numerical that do 
warrant further study in a larger group to elucidate if further differences could be seen.  
Understanding the relationship between DF fermentation in the child intestinal tract through non-
invasive, gentle and relatively inexpensive methods seems to be a viable option for assessing 
dietary factors on child health outcomes.     
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Table 4.1 Baseline characteristics (n=7) of parent and children pairs participating in the consumption of 10 g commercial cereal 
fiber with IOM recommended energy and fiber requirements.   
         
  Age (y) Ht (m) Wt (kg) BMI 
Energy Intake 
(kcal) 
Fiber 
Intake(g/day) 
Rec EER  
(kcal) 
Rec Fiber  
(g/day) 
Children 
        Female (n=1) 4.0 1.05 15.5 14.5 1174.9 kcal 10.7 1467 20.6 
Male (n=6) 5.6 ± 1.7 1.14 ± 0.07 21.6 ± 2.5 16.7 ± 1.8 1334 kcal ± 202 9.8 ± 2.5 1576 ± 72 22.1 ± 1.0 
Overall 5.4 ± 1.7 1.13 ± .08 20.7 ± 3.2 16.4 ± 1.8 1312 kcal ± 194 9.9 ± 2.3 1561 ± 77 21.9 ± 1.1 
Adults 
        Female (n=3) 36.3 ± 4.3 1.63 ± 0.06 53.4 ± 2.6 20.1 ± 0.4 2154 kcal ± 395 22.3 ± 11.2 2066 ± 164 28.9 ± 2.3 
Male (n=4) 40.7 ± 6.8 1.79 ± 0.10 84.6 ± 24.5 26.0 ± 4.8 1979 kcal ± 545) 18.64 ± 9 2732 ± 451 38.2 ± 6.3 
Overall 38.8 ± 5.9 1.72 ± 0.11 71.2 ± 24.1 23.5 ± 4.6 2067 kcal ± 106 20.5 ± 7.3 2446 ± 487 34.3 ± 6.8 
* All values represent the mean ± standard deviation. 
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Table 4.2 Main effect for time of commercial cereal fiber consumption on bowel function and 
intestinal symptoms   
Sympotoms Diaries Week 1 Week 2 Week 3 
St. 
Error 
p-
value 
General Well Being (1-5) 1.93 1.86 1.93 0.28 0.73 
Flatulence (1-5) 2.57 2.36 2.00 0.37 0.06 
Abdominal Pain (1-5) 1.21 1.14 1.43 0.16 0.18 
Bloating (1-5) 1.50
a 
1.07
b
 1.21
ab
 0.14 0.03 
Stool Consistency (1-5) 3.43 3.43 3.36 0.22 0.89 
Change in Bowel Movements (1-3) 1.86 1.93 1.93 0.08 0.73 
1= excellent or no symptoms, 5= poor, or extreme symptoms 
ab 
Values with different superscripts are considered significantly 
different (p < 0.05) 
   
Table 4.3 Main effect for age with commercial cereal fiber consumption on fecal short chain 
fatty acids and pH 
Fecal Measures Adult Child St. Error p-value 
   Acetic Acid 28.46 29.59 0.42 0.08 
Propionic Acid 112.67 121.54 5.94 0.27 
Butyric Acid 133.91 160.48 27.78 0.51 
pH 7.11 7.17 0.17 0.17 
ab
 values with p=0.05 are considered significantly different for adult vs child, and pre vs post 
consumption 
Values of SCFA are in µmol 
 
Table 4.4 Main effect for time with commercial cereal fiber consumption on fecal short chain 
fatty acids and pH 
Fecal Measures Pre Post St. Error p-value 
Acetic Acid 28.77 29.28 0.41 0.38 
Propionic Acid 106.71 127.49 5.94 0.02 
Butyric Acid 136.11 158.28 21.76 0.26 
pH 7.26 7.03 0.14 0.14 
ab
 values with p=0.05 are considered significantly different for adult vs child, and pre vs post 
consumption 
Values of SCFA are in µmol 
   
 
Table 4.5 Main effect for age with commercial cereal fiber consumption on breath fermentation 
and OCTT  
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Breath Values Adult Child St. Error P-value 
Time Peak Hydrogen 171.43 147.86 0.87 0.37 
Time Peak Methane 139.29 121.07 16.33 0.45 
Fasting Hydrogen Conc. 3.71 4.43 0.88 0.41 
Hydrogen iAUC 4758.04 3283.88 960.89 0.23 
Methane iAUC 1304.27 836.93 257.47 0.14 
Total Hydrogen ppm iAUC 6115.14 4122.88 1100.52 0.15 
OCTT 72.86 64.29 6.19 0.35 
 
Table 4.6 Main effect for time with commercial cereal fiber consumption on breath 
fermentation and OCTT 
Breath Values Pre Post St. Error p-value 
Time Peak Hydrogen 158.57 160.71 15.58 0.87 
Time Peak Methane 135 125.36 16.63 0.69 
Fasting Hydrogen Conc. 3.5 4.64 0.85 0.12 
Hydrogen iAUC 4497.95 3543.96 885.43 0.27 
Methane iAUC 1089.63 1051.57 257.47 0.9 
Total Hydrogen ppm iAUC 5559.52 4678.5 1050.04 0.4 
OCTT 68.57 68.57 4.52.45 1 
 
 
Table 4.7 Significant interaction effects for age and time following commercial cereal fiber 
consumption.  
Interaction Effects 
Adult 
Pre 
Adult 
Post 
Child 
Pre 
Child 
Post 
St. 
Error p-value 
Butyric Acid 144.85
ab
 122.97
a
 127.37
a
 193.59
b
 30.77 0.04 
*Fasting Hydrogen *2.42
a
 *5
b
 *4.57
ab
 *4.29
ab
 *1.0025 *0.0567 
ab
 Interactions with different superscripts represent significantly (p = 0.05) different responses  
 * Fasting Hydrogen values were only a trend, but express what numerical differences might have been present 
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Figure 4.1 Pre-Post Pattern of Breath hydrogen, methane, and total hydrogen’s (ppm) 
produced over time. 
 
 
Figure 4.2 Adult vs Child pattern of Breath hydrogen, methane, and total hydrogen’s 
(ppm) produced over time.   
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Chapter 5 - Metabolic Implications of Fiber Consumption: The Link 
Between Gut Microflora and Health 
 Introduction 
 Ever increasing attention is being aimed towards children 
1
 to provide a healthy 
base in nutrition as recommended by IOM, intending to prevent associated problems as children 
are following the same path as their adult counterparts 
2
.  Fiber has been identified to help 
prevent and treat obesity in adults 
3
, as well as youth 
4-6
.  Clinical evidence in children is limited 
7-10
 allowing for the adjudication of observational studies.  However, many hypotheses have been 
generated looking into the mechanisms to better understand the role DF may play in, “Health.”   
It has been suggested that all of the health benefits due DF sources such as whole grains, could 
be derived from fermentation of DF by the bacteria present in the large intestine (8, 9). 
 Although, there are many hypotheses that have been postulated as the mechanisms for 
fibers’ health implications, gut bacteria have played a relatively small one until recently.  It 
seems likely that many mechanisms play a role in fibers health promoting characteristics, but the 
complexity is only beginning to be understood.  Current attributes bestowed upon fiber may 
indeed be interactions mediated by the gut microflora.  A major role for DF, among many others, 
is to provide fuel for bacterial fermentation in the large intestine.  These bacteria possess 
enzymes that allow for their utilization of materials not processed by the human small intestine.  
It has been estimated that 60-70 g of carbohydrates are necessary to maintain the mass of colonic 
microflora found in the large intestine (LI) 
11,12
.  These bacteria are being researched for their 
ability to impact health, specifically: metabolism, physiology, immune function, and disease 
development 
13-18
. 
The Institute of Medicine (IOM) recommends the consumption of 14 g/1000 kcals, which 
approximates about 38 g for the Reference man of 154 lbs.  This represents roughly half (54.3%) 
of the estimated mass necessary for microflora homeostatis.  Research suggests, the rest of that 
gap is likely filled by starch.  Current estimates of starch malabsorption estimate approximately 
~10-20% of starch escapes digestion 
19,20
.  Essentially, any component resistant to digestion, 
becomes a source of food for the LI 
21
.  Thus, these indigestible components of food may provide 
a significant tool for dietary modulation of gut microbiota 
22
.   The proper categorization and 
identification of DF to include these components is important to progress towards accurate 
79 
 
measurement and would add greatly to our ability to translate that information into guidelines.   
It seems likely that DF could be the major direct or indirect contributor to fuel delivery to the 
large intestine and potentially, the single most important factor of gut modulation.  
 The idea of altering the gut microbiota has recently been a hot topic in nutrition and 
public interest.  Prebiotics and probiotics have been investigated for their ability to impact health 
on many levels 
23-25
.  Prebiotics are the substrates necessary to provide fuel for microbial growth.  
Probiotics are the delivery of the live biological organisms, themselves.  These are not exclusive 
to adults, as the potential to provide a healthy base via pre and probiotics in infants 
26
 has also 
been reviewed.  It stands to reason that we could consume a particular food substance; this 
substance will fuel certain bacteria, and thus, alter our health for the better.  To take this a step 
further, in theory we could prepare children for the best possible nutritional start in life, from 
breast feeding (a significant source) through weaning and beyond.  However, there is still a large 
gap in knowledge allowing us to delve in this train of thought, including the idea of an “ideal 
bacterial composition.” 
 The idea of a “normal” or “indigenous flora” is not new 27 and seems difficult to 
characterize.  These bacteria that should reside in our LI historically have been coined 
autochthonous microbiota 
27
.  More recently, the complexity of this concept coupled with the 
human body has taken on another term, cohesive with the technology that has allowed this 
insight, known as “microbiome” 28.  The name given to the concept that both the human and the 
bacteria in the LI have a vast genomic diversity that work together (almost one), assumedly for 
health or lack of it.  It is presumed that we can modulate this ecology for the improvement of 
health.  Improvements would come from both direct and indirect effects of the bacteria. Direct 
effects are likely to result in interactions of the bacterial cells with the host through 
immunological response.  These responses can range from toll-like receptor (TLR) activation
29
, 
to simply preventing pathogens adhesion
30
.  Indirect effects are the focus of this study, which 
include the by-products from bacterial metabolism and their interaction with our LI and body at 
large.    
 Research has shown microflora that reside in the LI are detected in different 
concentrations based on dietary modulation, which in turn would presumably alter the by-
products produced.  Changes have been noted in response to resistant starch (RS) 
31,32
 and 
oligosaccharides (OG) 
33,34
.  As bacterial populations and genera shift, this results in changes in 
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the metabolic by-products that are produced.  These fermentative products include short chain 
fatty acids (SCFA), lactate, which concurrently lowers pH.  Reducing pH subsequently lowers 
conversion to secondary bile acids, phenols, and ammonia concentrations
22,35,36
.  The SCFA 
commonly produced are acetate, propionate, and butyrate 
36
.  In addition to a lower LI pH, they 
can be utilized by the colonocytes as fuel and absorbed into the portal blood for utilization by the 
body.  Recent research is suggesting a prominent role in SCFA production and absorption 
affecting blood metabolic markers of disease, such as blood triglycerides (TG) 
37
.   
 In addition DF has been implicated with bowel dysfunction.  The major dysfunction that 
has been associated with fiber intake is constipation.  Intake of DF has been found to be lower in 
children presenting with constipation, than unconstipated children 
38,39
.  In addition, DF intake 
has been associated with colon cancer, diverticular disease, and oro-cecal transit time 
(OCTT)
21,40
.  This seems logical as increasing intake of DF has been associated with increasing 
stool weight and evacuation frequency 
21
.  Recently, the hydrogen breath test (HBT) has been 
utilized to measure OCTT 
41,42
.  Measuring the OCTT has been found to be an important 
indicator of bowel function and motility.  Thus, could provide meaningful contribution to the 
assessment of gut function.         
Based on the lack of knowledge towards this area and the presumption of control, we set 
out to contribute to a base of knowledge to investigate the application of these concepts.  
Understanding how DF affects the children is important 
43-45
 and more specifically the gut.  
Current recommendations for children are the same as adults 14 g/1000 kcal 
46
.  Children often 
have higher metabolic requirements and thus make the current level of fiber level quite high, 
potentially unrealistic.  Children are different in regards to nutritional requirements and 
anatomical considerations.  Anatomical consideration may be especially important when 
considering DF consumption.  This study intends to provide information discussing feasibility of 
non-invasive measures to study DF metabolic interaction in the bodies of children.   The 
objective of this study was to determine the impact of 10 g of DF supplementation for 21 days on 
gut community analysis by pyrosequencing and their correlation to metabolic markers of 
fermentation.  This will be the first study that we know of to provide a snap-shot of the gut 
microflora relative to non-invasive metabolic indicators of DF fermentation in the gut.  The 
hypothesis was that gut bacterial communities will shift after three weeks DF treatment and will 
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show significant differences between child and parent, and pre and post dietary fiber 
consumption.     
 Materials and Methods 
 Participants 
Parents and children were recruited from the Kansas State University (Manhattan, KS) 
community through e-mail list-serves and fliers.  Fliers were attached to e-mails or handed out at 
local pre-schools, child care centers and through University announcements.  Interested parties 
met with researchers to review complete protocols with both the parents and the children before 
signing consent/assent forms.  Exclusion criteria were treatment with antibiotic within one month 
of the study, vegan, a history of gastrointestinal disorder and dislike of cereal products.  Eight 
parent/children combinations consented to participation in the study, with a total participation of 
16 individuals.  One pair was excluded for analysis for failure to meet study expectations.  This 
study was approved by the Institutional Review Board of Kansas State University (IRB #6091).   
 Test Sample 
Participants were asked to consume a commercially available cereal product (Kellogg’s 
Fiber Plus, Cinnamon Oat Crunch, Kellogg’s) that contains approximately 1 gram of fiber as 
measured by TDF (Nutritional Facts Label) for every 3.5 g cereal.  The cereal is primarily whole 
grain oat flour with soluble corn fiber and corn bran as the main ingredients.  Providing fiber 
from this source allowed a feasible and appealing method for fiber delivery to young children 
that was also suitable for adults.  Participants were provided 10 g TDF or 35.5 grams of cereal 
and asked to consume the amount provided each day and avoid carry-over or “doubling up.” 
 Study Design 
The study was designed to investigate the change in colonic microflora over three weeks 
between adults and children with increased DF intake of 10 g/day, providing near the 
recommended dose of fiber per day by the IOM.  Three weeks has been shown to be sufficient 
for measuring fermentation changes 47-49.  Parents and children provided baseline 
measurements and were asked to consume the cereal for twenty-one days.  Participants were 
allowed one “free day” out of every seven days to help ensure compliance.  In addition, weekly 
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symptom diaries were completed by participants each week as self-reported bowel movement, 
discomfort, flatulence, bloating, stool consistency and overall general well-being.  Responses 
were marked on a scale of 1 to 5 (1 being optimal/normal and 5 worst/abnormal).   
 Study Variables 
Measurements were taken at the Foods and Nutrition Laboratory and KSU.  Participants 
were measured at baseline for height and weight, in addition to Three Day Diet Record (3DR) to 
record food intake.  Measurements collected at baseline and post fiber treatment were oro-cecal 
transit time (OCTT), fecal short chain fatty acids (SCFA), fecal pH, fecal bacteria as measured 
by 454 pyrosequencing and total hydrogen, methane production at 4 hours post lactulose load 
after an overnight fast.  Weight assessed using Ohaus ES 200L/Series scale (Ohaus, Corporation, 
Parsippany, NJ) with measures occurring in duplicate and a third measurement was taken if 
readings were more the 0.1kg apart.  Height was assessed via Seca wall-mounted stadiometer.  
Measures were taken in duplicate and were repeated if they were more than 5 mm apart.  
Averages were reported for both height and weight with standard deviation and were used to 
calculate their body mass index (BMI).   
 Food Record 
Participants were instructed to report their food intake utilizing the 3DR.  Intakes were 
only recorded at baseline to represent typical intake at the time of the study and assumed to be 
relatively similar throughout the duration of the study period.  Parents were instructed to record 
the intake of two weekdays and one weekend day for both themselves and their children.  They 
were encouraged to choose consecutive days, but also choose days that would be the most 
representative of the habitual intake.  Proper completions of the 3DR were orally discussed with 
all parents.  In addition, written instructions detailing examples of the proper information and 
way to record foods were given to each parent.  An example diet record as well as sample 
conversions were also provided.  Participants were encouraged to e-mail and call at any time if 
questions arose.  These assessments were primarily used to determine the total macronutrient 
make-up, caloric intake, and DF consumption.    
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 Breath Hydrogen Test 
Oro-cecal transit time, total hydrogen (ppm), total methane (ppm), and total H
+ 
(ppm) 
were measured via the breath hydrogen test (BHT) over 4 hours at 0, 30 45, 60, 75, 90, 105, 120, 
150, 180, 210, and 240 minutes.  Lactulose was given based on its ability to resist small 
intestinal digestion, thereby providing a reliable and repeatable source of fermentable substrate 
50-52
.  Participants were given 0.25 g lactulose / kg body weight, up to a max dose of 10g.  We 
felt it was important, especially in children to provide a size based approach to dosing in order to 
truly evaluate fermentative capacity.  To our knowledge, only one other study has provided 
evidence for this size-based approach and was further evidence for our methodology 
53
.  
Determination for OCTT was determined as the first time marked by three consecutive rises in 
breath hydrogen that cumulatively are ≥ 10 ppm, or two consecutive rises where the cumulative 
is ≥ 20 ppm total 54,55. 
Breath samples were extracted from the GaSampler reusable collection bag (Quintron 
Instrument Co, Milwaukee, WI, QT00841-P) with Monoject 35 mL plastic syringe (Quintron 
Instrument Co, Milwaukee, WI, QT-01735-V) fitted with a 1-way plastic stopcock (Quintron 
Instrument Co, Milwaukee, WI, QT01727-V).  A total of 30 mL was extracted from the reusable 
collection bag and injected within two-hours of collection into the BreathTracker SC (Quintron 
Instrument Co, Milwaukee, WI, QT05000-M).  Participants received their own collection bags 
and were the only individuals to use those bags throughout the duration of the study.  Total H2, 
CH4, and CO2 were recorded for each measure and were normalized according to CO2 of 5.5%, 
which is a valid way of correcting for dead space and atmospheric contamination 
56
.  To ensure 
samples were not diluted, dead-space air was eliminated by calibrated air discard sac.  This 
allowed for the disposal of up to 750 ml of dead space air, once the blow-off sac was full, air was 
automatically diverted through a one-way valve for collection of alveolar air or end-expiratory 
air 
52
.       
During the test, participants came in after a 12 hour fast.  Participants were instructed to 
consume a low fiber meal and were presented alternatives when necessary.  The same meal was 
consumed the night before each test.  When the previous condition was not possible a low fiber 
meal was consumed in its place.  Participants were also advised to consume light meals with no 
snacking after supper and no alcohol.  During the test, participants were to be awake, refrain 
from caffeine, smoking and exercise.  Due to the age of the participants, easily digestible snacks 
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were provided in less than 200 calories to prevent passing of carbohydrate beyond the small 
intestine.  The same snack was consumed in the pre and post trial to ensure both test were treated 
equally.  Hydrogen and methane values were used to calculate incremental area under the curve 
(iAUC), hydrogen, total methane, and total H2 ppm.  The lowest value achieved prior to a 
sustained rise in breath hydrogen was defined as the basal hydrogen level 
52
, which was also 
applied to methane and cumulative H2 atoms.  Basal hydrogen level was then used as the 
baseline for iAUC calculation. 
 Bowel Habits/Symptoms Diaries 
Symptom diaries were self-reported by participants and parents verbally explained the 
survey for children and reported their responses.  Symptoms/habits measured included bowel 
movement, discomfort, flatulence, bloating, stool consistency and general well-being on a scale 
from 1 to 5 (1 being optimal/normal and 5 worst/abnormal) as previously reported (31). 
 Stool Collection and Preparation 
Stool was collected within 3 days prior to the first study day and the same prior to study 
completion.  Stool was received within one hour of voiding and processed within two hours.  If 
samples were not immediately prepared and stored, they were placed in 7°C until processed 
within the two-hour time limit.  Samples were homogenized with Sterileare (Bel-Art Products) 
sampling knife manually.  In a 50 mL Corning Centrifuge Tube, 27 ml of Phosphate Buffered 
Saline (PBS) were pipetted.  To the PBS, 3 g of stool were added, and the mixture was 
homogenized using vortex for approximately 30 seconds to one minute.  Cryovial (Fisherbrand, 
2ml) were filled with approximately 1.5 ml homogenized stool/PBS slurry.  Samples were stored 
in -80°C until further processing.     
 Fecal pH 
Fresh fecal samples were packaged with sterileware
®
 plastic knife (Bel-Art Products) in 
bulk Nalgene
®
 Specimen Collection Cup 15 mL Cryogenic Screw-top vials (Thermo Scientific).  
Samples were subsequently thawed and two grams were mixed in a 1:5 dilution with distilled 
deionized (DD) water and homogenized for pH (Accumet pH Meter 25).  Measurements were 
reported as average of triplicate repeated measures.   
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 Fecal SCFA 
Fecal SCFA samples were diluted in a 1:5 w/v with double distilled water and 
homogenized and prepared according to previous works 
57
.  Briefly, samples were homogenized 
for 3 min and adjusted to pH 2-3 with 5 M HCL, and kept at room temperature for 10 min with 
gentle agitation.  Modifications to match equipment include placing the homogenate in a clean 
polypropylene tube and centrifuged for 10 min at 3,500 rpm.  Supernatant was then transferred to 
2.0 ml microcentrifuge vials and centrifuged for 10 min at 8,000 x g.  The clear supernatant was 
then transferred and spiked with 2-ethybutyric acid as an internal standard.  The final 
concentration of 1mM and 1 µL was injected for analysis.  Standard stock solutions were 
prepared with aqueous concentration of 400mM for acetic acid, propionic, and butyric acid.  
Stock solutions were stored at -20°C .  
 Chromatographic Conditions 
Analysis was carried out using Agilent 6890 GC, equipped with a flame ionization 
detector (Agilent, USA) and PALcombi-xt (LEAP, Lake Elmo, MN) autosampler.  The column 
was a Nukol
TM
 FUSED SILICA Capillary Column (SUPELCO, Bellefonte, PA, USA) with 
dimensions of 30 m x 0.53 mm i.d. coated with 0.50 µm film thickness.  Methods used have been 
previously described 
57
, but nitrogen was replaced with helium as the make-up gas at a total of 20 
mL/min.  Data recording and anaylsis was carried out with HP ChemStation Plus software 
(A.10.02, Agilent).  
  DNA Extraction from Fecal Samples 
Fecal Homogenates were thawed and approximately 2 mL were used to recover by 
centrifugation (8,000 x g, for 5 min at room temperature).  Cells were recovered, approximately 
0.50 g and were added to MOBIO PowerSoil Kit (MOBIO Laboratories, Inc., Carlsbad, CA, 
USA).  Manufacturer’s instructions were followed to complete the extraction.  Extracts were 
checked for quality and quantity using the NanoDrop ND-1000 (ThermoScientific, UV-VIS, 
Wilmington, DE).  Samples were standardized based on concentration and stored at -20°C.  
Samples were thawed and prepared in 96 well nuclease free plates for the primary PCR reaction 
as follows.  Reaction mixture consisted of 25 µL of Master Mix (AmpliTaq Gold 360 Master 
Mix, Applied BioSystems, Life Technologies, Carlsbad, CA), 5 µL template (10 ng/ µL), 5 µL 
primer forward (IDT), 5 µL primer reverse (IDT), and 10 µL NCF H2O.  Forward primer set was 
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a FC9F-GAGTTTGATCCTTGGCTCAG and the reverse primer set was FC541R-
TTACCGCGGCTGCTGG targeting the bacterial 16s rRNA.  Thermocylcer conditions were set 
with an initial denaturing step at 95°C 8 min and lid temperature of 105°C.   Cycle conditions 
with denaturing step of 30 sec, annealing for 1 min at 54°C, and extension for 2 min at 72°C, for 
24 cycles.  A final elongation step was held at 72°C for 10 min.  Samples were frozen in -20 
until further analysis.  Secondary PCR reaction was performed under the conditions above for 5 
cycles to attach barcode and adapter sequencing with GSFLX Titanium reagents for 454 
sequencing.  Individual samples were amplified and pooled, allowing for mixing of PCR 
products into a single run.  Templates were pyrosequenced at the K-State Integrated Genomics 
Facility (IGF).       
Samples were cleaned using AMPure XP (Agencourt, Beverly, Massachusetts) according 
to manufacturer conditions.  Samples were checked for quantity and quality using the NanoDrop.  
Samples templates were concentrated for 55 min at on low heat at 1,500 RPM.  Samples were 
cleaned a second time and check with NanoDrop and standardized according to total DNA 
concentration, samples were stored at -20°C.  Samples were Bioanalyzed with 1 µl of template 
using the DNA 1000 kit for final quality and quantity check before pyrosequencing. 
 Sequence Processing 
 
Sequences were processed using the mothur community analysis program 
58
.  Sequences 
were extracted from the raw 454 data and extracted for fasta, qual, and flow files.  Summarizing 
our fasta file revealed approximately 233,000 sequence reads.  Flow files were “quieted” using 
the translated de-noising algorithm via mothur.  Sequences were then trimmed for removal of the 
barcode and adapters, as well as removal of homopolymers and sequences less than 200 
nucleotides in length.  Aligned sequences were checked for coverage, richness, and diversity 
indicators and approximately 450 sequences were used for taxonomic classification at 97%.  
Sequences were assigned to a bacterial phylum, family, and genus.         
 Summary 
 
 Although, specific interpretable results cannot confidently be documented at this time, 
the author felt it was important to provide written documentation up to this point.  Provided here 
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is a framework from which to follow for future work.  Appendix B is dedicated to providing the 
basic framework to all of these procedures to allow for future researchers to have a 
conglomeration of information from which to move forward within the field of human nutrition.  
Upon publication of the results, the paper and the dissertation can give a complete picture of the 
experimental process for future guidance.     
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Chapter 6 - General Conclusions 
There are apparently feasible ways to characterize the metabolic fate of DF in children 
that are non-invasive, gentle, and cost-effective manner.   There was not an acute fermentative 
response of breath methane and hydrogen from increasing DF dose in free-living children (3-5 y) 
in our study.  However, based on previous studies and the free-living nature of this study, it is 
possible a dose-response could be detected with a longer follow-up.  Further research is 
necessary to determine the follow-up time and proper interval sampling required to determine 
DF fermentative characteristics in a free-living population of children, while controlling for fiber 
intake.  Non-invasive markers of fermentation correlate well in in-vitro studies, but interpreting 
in-vivo results is challenging and will require more carefully controlled studies from all 
disciplines to add to the basic functions of the gut.  The results of our studies together suggest 
that the biological variability is large between individuals.  We provided some evidence showing 
little differences between children and adults as assessed by these methods; however, there was 
also some evidence pointing to the contrary, and a larger study is warranted with fiber-controlled 
diets.  Overall, it is difficult to apply these findings given the variability in the results and the 
small sample sizes.  In addition, there is limited evidence characterizing measureable outcomes 
of DF fermentation.  In free-living individuals, these findings seem to indicate that there are not 
many differences based on fiber consumption.  Dietary fiber requires clarity on definition, 
measurement, and basic knowledge of the gut in order to improved recommendations.  Currently, 
there seems to be no serious implications of large amounts of DF consumption, minus intestinal 
discomfort that can be adapted too.   This work provides a framework from which to move 
forward in understanding not only the child gut, but the gut in general.             
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Appendix A - Chapter 3 Supplemental Materials 
DEPARTMENT OF HUMAN NUTRITION 
KANSAS STATE UNIVERSITY 
 
 PARENTAL PERMISSION SLIP 
Measurement of Fiber Intake Using Breath Samples 
 
Principal Investigator:    Mark Haub, PhD 
Research Assistants:     Casey Weber, MS, James Lattimer, MS, Greg Tanquary 
 
Project Information:  The perception of dietary fiber as healthy in adults is common.  
However, the effects in children are poorly understood.  There is limited evidence that requiring 
fiber intake in children will result in improved health outcomes now or in the future.  To better 
understand how dietary fiber recommendations and subsequent changes affect children it is 
important to have data illustrating how fiber is interacting in the bodies of children.  The goal of 
this study is to non-invasively determine the dose-response of fiber consumption in children by 
measurement of breath hydrogen and methane content in commonly provided food.  The intent is 
to obtain data that illustrates how fiber affects the body.  Particularly, in the developing human 
gut and translate that to information researchers and food companies can use to assess the 
potential healthfulness of a fiber intake.       
  
What’s Involved:  If you choose to participate, your child will be asked to consume a 
breakfast cereal before coming to Stone House on four occasions and collect a quick breath 
sample.  We will also require that you fill out a form designating the approximate amount cereal 
not consumed if this was not possible, time of consumption and some information regarding the 
meal the night before.  We will need to know if your child has had gastrointestinal concerns as 
this study may not be appropriate for them as it may cause stomach discomfort.  All materials 
will be provided to you in advance.  In addition, we will then ask if your child has recently been 
on any antibiotics or gastrointestinal motility drugs as they may affect the results of the study.  
We will need to ensure a time, perhaps at drop-off or pick-up your child to explain the project in 
full.  Foods that will be provided for your child to consume are all purchased at a local grocery 
store (cereal) and will be further discussed with you at the time of enrollment.  We ask that if you 
are aware of any allergies (e.g. peanuts) or intolerances (e.g. lactose) your child may have, that 
you let us know.  You will always have the opportunity to withdraw from the study regardless of 
the reason.   
 
Description of Breath Test:  The breath collection and analysis procedure has been most 
developed for clinical testing for malabsorptive disorders (lactose, fructose), Small Intestinal 
Bacterial Overgrowth (SIBO), and oro-cecal transit times (time required for food to reach the 
colon).  Bacteria in your body are the only sources of hydrogen and methane production 
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occurring from fermentation of food in the large intestine.  When the bacteria produce these 
gases, some are released through your breath in much the same manner as CO2 is release through 
your breath.  Fiber is typically considered to be “resistant” to digestion and will pass into your 
large intestine largely unaltered.  In the large intestine (where bacteria normally reside) any 
carbohydrate, including fiber that exist will be available for bacterial digestion.   
The test will begin the night before as children will need to be fasted for 8-10 hours.  
Water is permissible during that time, however, food and other beverage consumption may alter 
the reliability of the test.  A baseline breath test will be necessary, followed by cereal 
consumption.  We will then take measures approximately every 30 minutes for 5 hours while 
your children are completing a typical day’s activity at Stone House.  After measurements are 
completed will we be able to see a graphical representation of the Hydrogen and Methane gas 
released by bacteria in the colon   
 
Anthropemetric Measurement:  For anthropometric measurement, we will be assessing 
Body Mass Index (BMI), by collecting children’s body weight using a digital scale, and height 
using a standard stadiometer.  Children will be measured away from other children’s line of sight 
with two technicians and the parents will be encouraged to be present.  Measurement of BMI 
will only occur at one time point.  For body composition, we will use a common measure, the 
Bioelectrical Impedance Analysis (BIA).  Children will lie in a comfortable position and a small 
electrode will be place on the right ankle and right foot.  This device will send a very low current 
to determine how quickly the charge moves through the body.  The charge is not noticeable and 
does not physiologically interfere with the body (same principal as a common bathroom scale).  
The procedure will allow for estimation body water for calculation of body composition from 
this measure.  The measure will last 2-3 minutes and will be taken only once at the beginning of 
the study.  
 
Potential Benefits and Concerns:  At the conclusion of this project, you will obtain your 
child’s information related to this study.  We will also provide a brief interpretation of the 
information that we obtain.  The results of this study will be the first of their kind and will 
contribute immensely to the impact of dietary fiber in children.  The results provide the 
opportunity for many more projects and idea generation regarding fiber intake and health.  
The potential risks are minimal, but may include the following: 
Gas production that may result in flatulence, belching, and stomach discomfort.  We will be 
inquiring information about normal fiber consumption and your child will be provided less than 
the recommended amounts of fiber for consumption, which will reduce risks of stomach 
discomfort.   
 
 Debriefing:  After the final trial you will receive all results as well as the interpretations 
of the information obtained.  Also, the investigators would be more than happy to answer your 
questions over the results or any other part of the study at any time.   
 
Alternative Procedures:  None.  You and your child may decline to participate or 
withdraw at anytime from this project without prejudice or penalty. 
 
Time Commitment:  There will be a slight additional commitment the four mornings 
before the study.  This commitment will entail obtaining an initial breath sample and 
remembering to provide the cereal to your child the morning of the study.  All materials needed 
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along with any instruction will be provided to you and we will always be available for questions 
or concerns.  Otherwise your day will be normal and the child’s routine will be the same as 
currently provided at Stone House.        
 
Confidentiality:  All records associated with your participation in the study will be 
subject to confidentiality standards applicable to medical records, and in the event of any 
publication resulting from the research no personally identifiable information will be disclosed.  
All medical records will be kept confidential, with the possible exception of review by the 
University Research Compliance Office at Kansas State University – Dr. Rick Scheidt at 
(785)532-3224. 
 
Right to ask questions:  You have been given the opportunity to ask any questions you 
may have to your satisfaction.  If you have any further questions about the study or your 
participation in it, please contact the following investigators at your convenience.  
Mark D. Haub, Ph.D. (haub@ksu.edu) (785)532-0170 -- (785)776-4282 -- (785)320-3330 or  
Casey Weber (cweb81@ksu.edu)  (785)410-6490 – (785)532-0170 
 
Compensation:  You will be given a gift card to Wal-Mart $20 after completion of this 
study.  In case of complications, physical injury, or illness resulting from the proposed research, 
only acute and essential medical treatment is available.  This institution will not provide 
monetary compensation for wages lost as a result of injury, hospitalization, and/or professional 
services.  
 
Voluntary Participation: Please understand that your child’s participation in this study is 
voluntary, and that you may withdraw from this study at any time by notifying the investigator.  
Your withdrawal from this study or refusal to participate will in no way affect your care or 
access to medical or educational services or participation in future studies.  Your participation in 
this research may be terminated by the investigator without regard to your consent if you are 
unable or unwilling to comply with the guidelines and procedures explained to you.   
I understand this project is research, and that my participation is completely voluntary. I also 
understand that if I decide to participate in this study, I may withdraw my consent at any time, and 
stop participating at any time without explanation, penalty, or loss of benefits, or academic standing 
to which I may otherwise be entitled. I verify that my signature below indicates that I have read and 
understand this consent form, and willingly agree to participate in this study under the terms 
described, and that my signature acknowledges that I have received a signed and dated copy of this 
consent form. 
 
    Please mark one box, sign, and return to the program as soon as possible: 
 I will allow my child to participate in having their breath, heigh, weight, and body 
composition. measured and has no known digestive conditions (list of potential conditions can 
be found below).  
 I will not allow my child to participate. 
 
Parent Name   ________________________________________ _______________ 
    (Please  print )     (Date) 
 
Parent Signature  ________________________________________ _______________ 
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Child’s Name:       _______________________________ Child Date of Birth: 
______/_______/______ 
 
 
Potential Digestive Conditions: 
 
Malabsorptive Disorders 
 
Lactose Intolerance 
Fructose Intolerance 
Glucose Intolerance 
 
Intestinal Disorders 
 
Small Intestinal Bacterial Overgrowth 
Crohn’s Disease 
Ulcerative Colitis 
Chronic Constipation 
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 Questionnaires 
Take-Home Survey 
 
 
In the Past 1 week: 
 
1. Has your child had normal stool this week?   
a. If inclined, please describe (This will increase our interpretation) 
 
2. Has your child required an antibiotic recently for the treatment of an infection, i.e. ear 
infection, eye infection,   
 
Last Night: 
 
1. Were food any foods consumed during supper last night that may have had fiber in them?  
a. If so, please elaborate on type of food and amount consumed: 
 
 
 
2. Was a snack necessary after supper?  
a. If so, please list the snack and amount consumed: 
 
 
This morning: 
 
 
1. What was the approximate time your child provided the breath sample?   __________ 
 Was the cereal able to be consumed shortly after this time? __________ 
 
2. Was your child able to completely consume the cereal?   __________ 
 
 
 
3. Was milk necessary?  If so, what kind? (i.e. Whole, 2%, skim, soy)  __________ 
 
Further Comments (Please feel free to list any comments or questions you may have): 
 
Thank you very much! 
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 Recruitment Fliers 
Participants needed for study involving the understanding of colonic 
health in children (3-5) 
 
What is involved:  The study would require consumption of cereal for three 
weeks; accompanied by collection of two stool samples and two visits to Justin 
Hall.  Each visit to Justin Hall would require approximately 6 hours.  Children will be asked to 
breathe into a gas collection bag (which is very close to a normal balloon) at regular intervals of 
30 minutes during the 6 hours.  During collection (10 seconds) periods children will be 
interacting with research staff and during non-collection periods (rest of the time) children will 
be entertained via games, movies and other activities designed for their age.  The first visit 
children will be monitored for height and weight for assessment of Body Mass Index (BMI).  In 
addition we will be conducting an analysis of body water to estimate body composition.  
Estimations of body water will occur with the use a Bioelectrical Impedance Analyzer (BIA); 
this works according to the same principles found in the common home weight scale.  In 
addition, we will be collecting height and weight values for calculation of BMI.  We will require 
collection of stool samples before consumption of cereal and after consumption. Parents are 
welcome and encouraged to stay for the duration of the study.     
 
Where:  Human Metabolism Lab, Justin 127, Kansas State University.    
 
Why is this research being conducted:  Currently, knowledge involved in 
understanding the role fiber plays in our large intestine is limited in children.  
Therefore, it is the intent of this research to help increase that understanding.  There are bacteria 
in the large intestine that ferment fiber, when they undergo this fermentation one effect that can 
occur is that gas is produced and released through normal breathing.  This is the same as 
breathing in oxygen and release of carbon dioxide in our breath.  This research intends to 
measure the quantity of two gases produced (hydrogen and methane) by collecting breath 
samples.  Obtaining an indication of the way gases are released by fiber fermentation we may 
have another indicator of health, much like a blood sample can tell our cholesterol levels and 
relate that to heart health.  The stool samples are needed to determine the type of bacteria that are 
present in the stools and to determine how the fiber from the cereal might have interacted with 
the bacteria in the large intestine.    
 
Who is involved:  Researchers from the Human Metabolism Lab, located on the campus of 
Kansas State University in Justin Hall.    
 
Participation:  This flier is simply inquiring on the interest in participating in a study of this 
nature; you or your child, are not required to participate in this study.   In addition, if you would 
choose for your child to participate in this study, at no time, would the child be required to 
participate and would have the option to withdrawal at any time.   
 
Interested in more information or participation? 
 
Contact: 
 
Casey Weber, M.S. (ABD) (cweb81@ksu.edu) (785)410-6490 or (785)-532-0170  or 
 
Mark Haub, Ph.D. (haub@ksu.edu)  (785)532-0170 or (785)776-4282 or (785)320-3330 
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 Take-Home Materials Provided 
 
 
 Pre-Day Testing Instructions 
 
The Night Before: 
 
Goal:   To avoid high fiber, complex carbohydrate containing foods. 
 Try to have a moderately sized meal 
 Try to limit food consumption to before 9:00 PM 
 
Example Foods: 
(If there is a food your child absolutely loves and will be difficult to give up, please talk 
to us) 
 
 Boiled White Rice 
 Baked Potatoes 
 Meats 
 Eggs 
 Soup broths 
 Fruit snacks, gummy, fruit juice 
 Lower fiber foods 
 
The Morning of:  
 
 -Water only (Until, cereal)  
 -Brush teeth (This is best done before breath test if possible, but is okay if not) 
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 Treatment BagReminder 
 
Reminder (On Sample to take home 
 
1. Rinse mouth or brush teeth 
2. Complete breath test 
3. Consume cereal, encourage without milk.  However, add milk if necessary.   
4. Encourage complete consumption (This may not always be possible.  
5. Remember to grab K-State bag, with: 
a. Breath Collector 
b. Extra cereal 
c. Completed Survey 
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 Research and Extension Fiber Information Flier 
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Appendix B - Chapter 4 Supplemental Materials 
DEPARTMENT OF HUMAN NUTRITION 
KANSAS STATE UNIVERSITY 
 
 PARENT & CHILD PERMISSION SLIP 
Comparison of Fiber Fermentation between Adults and Children 
 
Principal Investigator:    Mark Haub, PhD 
Research Assistants:     Casey Weber, MS 
 
Project Information:  The perception of dietary fiber as healthy in adults is common.  
However, the effects in children are poorly understood.  There is limited evidence that 
demanding that fiber intake in children will result in improved health.  To better understand how 
dietary fiber recommendations and subsequent changes affect children it is important to have 
data illustrating how fiber is interacting in the bodies of children.  The goal of this study is to 
non-invasively determine the changes incurred to a set-dose of fiber in both adults and children 
over the same time period.  The intent is to obtain data that illustrates how fiber affects the body 
of children and adults.  Particularly, in the developing human gut and translate that to 
information researchers and food companies can use to assess the potential healthfulness of a 
fiber intake, potentially later in life.       
  
What’s Involved:  If you choose to participate, you and your child and/or adults will be 
asked to make approximately 2 visits to Justin Hall (Hoffman Lounge) on a prescheduled Thurs, 
Friday or Saturday.  We will need to know if your child (or if you are the participant) has had 
gastrointestinal concerns as this study may not be appropriate for them (you) as it may cause 
stomach discomfort.  In addition, we will then ask if the potential participant has recently been 
on any antibiotics or gastrointestinal motility drugs as they may affect the results of the study.  
We will then set-up a schedule for you to attend two of the above time points for testing.  Foods 
that will be provided for the participants to consume are all purchased at a local grocery store 
(cereal and milk) and will be further discussed with you at the time of enrollment.  We ask that if 
you are aware of any allergies (e.g. peanuts) or intolerances (e.g. lactose) your child may have, 
that you let us know.  You will always have the opportunity to withdraw from the study 
regardless of the reason.   
 
Description of Breath Test:  The breath collection and analysis procedure has been most 
developed for clinical testing for malabsorptive disorders (lactose, fructose), Small Intestinal 
Bacterial Overgrowth (SIBO), and oro-cecal transit times (time required for food to reach the 
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colon).  Bacteria in your body are the only sources of hydrogen and methane production 
occurring from fermentation of food in the large intestine.  When the bacteria produce these 
gases, some are released through your breath in much the same manner as CO2 is release through 
your breath.  Fiber is typically considered to be “resistant” to digestion and will pass into your 
large intestine largely unaltered.  In the large intestine (where bacteria normally reside) any 
carbohydrate, including fiber that exist will be available for bacterial digestion.  The test will 
begin the night before as children will need to be fasted for 8-10 hours.  Water is permissible 
during that time, however, food and other beverage consumption may alter the test.  A baseline 
breath test will be conducted followed by a lactulose drink.  We will then take measures every 15 
minutes for 2 hours and every 30 minutes for up to 6 hours.  After all measurements we will be 
able to see a hydrogen/methane gas profile and oro-cecal transit time.   
 
Anthropemetric Measurement:  For anthropometric measurement, we will be assessing 
Body Mass Index (BMI), by collecting body weight using a digital scale, and height using a 
standard stadiometer.  Participants will be measured away in Food and Metabolism Lab (FML) 
with two technicians and the parents will be present in the measurement of the child.  
Measurement of BMI will only occur at the beginning of study.   
 
3 Day Diet Records: Participants will need to fill out a 3-Day Diet Record one time 
before the onset of the study.  This will be used to assess diet and the amount of fiber each 
individual receives.  The purpose for the use of these extensive forms is because they are the 
most representative method available to assess food intake.  In this way we will assess two 
weekdays and one weekend day with the goal of obtaining a normal dietary intake pattern.   
 
Symptoms Diary:  Symptom diaries will be filled out every week and will not be required 
to be returned until the final week.  Participants will be reminded every week via preferred 
method to ensure completion of the symptom diary is indeed accurate within reason for said 
purpose.  Symptoms assessed include:  bowel movement number, stool consistency, discomfort, 
flatulence, abdominal pain and bloating, and subjects were asked to score them on a scale from 1 
(none, normal, good well-being) to 5 (severe symptoms and discomfort).  One additional 
question will assess the compliance of sample consumption.  Should there be any unforeseen 
symptoms that cause more than mild discomfort participants should stop.   
 
Fecal Collection:  Participants will be provided stool collection containers.  In the case 
of children parents will be provided with the container.  Fecal samples will be collected 
immediately before and after the cereal consumption phase.  There will be a total 2 collections 
that will be processed for assessing changes in gut health (colon cells and intestinal bacteria).  In 
addition we will check the pH of the stool and short chain fatty acids, which are both indicators 
of fermentation.     
 
Potential Benefits and Concerns:  At the conclusion of this project, you will obtain your 
child’s information related to this study.  We will also provide a brief interpretation of the 
information that we obtain.  The results of this study will be the first of their kind and will 
contribute immensely to the impact of dietary fiber in children.  The results provide the 
opportunity for many more projects and idea generation regarding fiber intake and health.  
The potential risks are minimal, but may include the following: 
Gas production that may result in flatulence, belching, and stomach discomfort.  We will be 
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inquiring information about normal fiber consumption and your child will be provided less than 
the recommended amounts of fiber for consumption, which will reduce risks of stomach 
discomfort.   
 
 Debriefing:  After the final trial you will receive all results as well as the interpretations 
of the information obtained.  Also, the investigators would be more than happy to answer your 
questions over the results or any other part of the study at any time.   
 
Alternative Procedures:  None.  You and your child may decline to participate or 
withdraw at anytime from this project without prejudice or penalty. 
 
Time Commitment:  This study requires visits to the study center over four 
weeks/weekends.  Your total time commitment for this study will be approximately 8-12 hours 
(4-6 hours for each visit), plus 1 additional hour for potential paper work.   
 
Confidentiality:  All records associated with your participation in the study will be 
subject to confidentiality standards applicable to medical records, and in the event of any 
publication resulting from the research no personally identifiable information will be disclosed.  
All medical records will be kept confidential, with the possible exception of review by the 
University Research Compliance Office at Kansas State University – Dr. Rick Scheidt at 
(785)532-3224. 
 
Right to ask questions:  You have been given the opportunity to ask any questions you 
may have to your satisfaction.  If you have any further questions about the study or your 
participation in it, please contact the following investigators at your convenience.  
Mark D. Haub, Ph.D. (haub@ksu.edu) (785)532-0170 -- (785)776-4282 -- (785)320-3330 or  
Casey Weber (cweb81@ksu.edu)  (785)410-6490 – (785)532-0170 
 
Compensation:  Upon completion of completion of this study participants will receive 
$100.  This represent $50 for each visit to the Food and Metabolism Laboratory.  In case of 
complications, physical injury, or illness resulting from the proposed research, only acute and 
essential medical treatment is available.  This institution will not provide monetary compensation 
for wages lost as a result of injury, hospitalization, and/or professional services.  
 
Voluntary Participation: Please understand that your child’s participation in this study is 
voluntary, and that you may withdraw from this study at any time by notifying the investigator.  
Your withdrawal from this study or refusal to participate will in no way affect your care or 
access to medical or educational services or participation in future studies.  Your participation in 
this research may be terminated by the investigator without regard to your consent if you are 
unable or unwilling to comply with the guidelines and procedures explained to you.   
  
I understand this project is research, and that my participation is completely voluntary. I also 
understand that if I decide to participate in this study, I may withdraw my consent at any time, 
and stop participating at any time without explanation, penalty, or loss of benefits, or academic 
standing to which I may otherwise be entitled. I verify that my signature below indicates that I 
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have read and understand this consent form, and willingly agree to participate in this study 
under the terms described, and that my signature acknowledges that I have received a signed 
and dated copy of this consent form. 
 
    Please mark one box, sign, and return to the program as soon as possible: 
 I will allow my child to participate in having their breath, height and weight measured 
and has no known digestive conditions (list of potential conditions can be found, below).  
 I will not allow my child to participate. 
 
Parent Name   ________________________________________ _______________ 
    (Please  print )     (Date) 
 
Parent Signature  ________________________________________ _______________ 
 
Child’s Name:       _______________________________ Child Date of Birth: 
______/_______/______ 
 
 
Potential Digestive Conditions: 
 
Malabsorptive Disorders 
 
Lactose Intolerance 
Fructose Intolerance 
Glucose Intolerance 
 
Intestinal Disorders 
 
Small Intestinal Bacterial Overgrowth 
Crohn’s Disease 
Ulcerative Colitis 
Chronic Constipation 
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 Recruitment Flier 
Volunteers  
Needed 
In a Nutrition Fiber Study for Parents and 
Children 
 
This study will determine how related adults and 
children interact with fiber in their bodies. 
 
Considerations: 
1) Age 3-8 Children, Any age for parents 
2) Apparently healthy 
3) Willing to make two visits to Food and Metabolism Lab in 
Justin Hall for 4-6 hours 
4) Provide two stool samples 
5) Time spent in lab will be compensated 
 
If you find yourselves willing and eligible or have questions 
please contact us: 
 
Food and Metabolism Lab 
Casey Weber 
cweb81@ksu.edu 785-532-0170 785-410-6490 
or 
Dr. Mark Haub 
haub@ksu.edu 785-532-0159 
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 Three Day Diet Records 
 
Food and Metabolism Lab 
Kansas State University 
 
Food Record Instructions 
 
You will be keeping a food record for three or more consecutive days.  In order to 
complete the food record thoroughly, please make a note of all food and beverages consumed 
during the days you have been assigned, this includes gum, breath mints, etc.   
 
It is also important to note the method of preparation (e.g., fried, baked, broiled, etc) and 
all condiments (ketchup, mustard, mayonnaise, sauces, etc.) or other additives (salt, butter, sugar, 
nutrasweet®, etc.) that are consumed with the food.  So, if you have eggs for breakfast you need 
to record the amount of eggs, how it was prepared (fried, poached, etc.), what was fried with 
(vegetable oil, butter, etc.), anything you may have put on the eggs (ketchup, tobacco sauce, salt, 
pepper, etc.), and the time you ate.  Also, reporting the brand of food item is very helpful.  If you 
eat at a restaurant be sure to note if you excluded normal items (e.g., McDonald’s cheeseburger 
without ketchup and onions).   
 
Please do not overlook the importance of reporting the serving size or amount eaten, as 
this is the most important piece of information for us when calculating your dietary intake.  Do 
not hesitate to use comparisons such as equating the size of the serving to a deck of cards if you 
do not know the exact portion size.  Giving us any information to use will be very helpful – and 
we understand that most people do not measure their food to the nearest gram.   
 
Over the days when you are keeping your food record, you must tell us everything you 
eat and drink, even water and diet sodas.  Don’t forget about breath mints, gum, tobacco 
products, and vitamins/supplements.  All of these items contribute to your daily intake of 
nutrients and that is what we are interested in knowing – regardless of what it might be.   
 
If you ever have any questions regarding your food record, please contact the study 
manager (Casey Weber).  We will be more than happy to help – it is in everyone’s best interest 
to keep accurate food records for the success of this scientific study.   
 
Thank you Very much for your cooperation and dedication.  Your participation will 
not only provide information for you, but will also benefit science.   
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 Symptom Diary 
Name__________________________________  Subject Number______   Dates________________________ 
Please rank the following symptoms based on an average for each observation from this week using a 1-5 scale: 
General Well Being/Health: 
1 Excellent  2 Above Average  3 Average 4 Below Average 5 Extremely Poor     
 
Flatulence: 
1 None  2 Little  3 Somewhat  4 Much  5Excessive 
 
Abdominal Pain: 
1 None  2 Little  3 Somewhat  4 Much  5Excessive 
 
Bloating: 
1 None  2 Little  3 Somewhat  4 Much  5Excessive 
 
Stool Consistency: 
1 Watery 2 Fluffy/Soft blobs 3 Smooth/Snake-like 4 Lumpy  5 Small hard 
pieces 
        (w/ or w/o cracks) 
 
Have bowel movements in general (Please note if you feel comfortable any chages): 
Increased   Decreased  Stayed about the same? 
 
Comments: 
 
Has the cereal been consumed in one sitting or through-out the day, please note what has worked best? 
 
 
 
 
Please return any cereal not consumed.
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Appendix C - Bacterial Community Analysis Procedures 
 Fecal Sample Collection  
1. Collect fecal samples using fecal collection hat (system).   
a. Fecal collection hats –  
i. Fisher Sci – Fisherbrand – Commode Specimen Collection System 
ii. Catolog # - 02-544-208 – 60 for 201.62 
2. Ensure that samples are collected within 1 hr and processed with/in 2 hr. 
a. Nechvatal et al., 2010, Martinez et al., 2010 
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 Sample Preparation 
1. If multiple samples have been collected please ensure they are in the refrigerated 
conditions (32 – 37oF).  Samples may be removed when preparation is necessary 
2. Collect 3 grams of fecal sample and place in 27 g of Phosphate Buffered Saline (PBS) in 
a Corning 50 mL centrifuge tube 
a. Corning – Centrifuge Tube (or Falcon Tube) – 50 mL 
i. Cat # - 430291 – 25 tubes per bag 
b. Martinez et al., 2010 
c. This creates a 1:10 dilution or ratio for preservation 
3. Vortex sample until homogenized 
4. Place approximately 2 mL of homogenate into 4 microcentrifuge tubes.   
a. Dispose of extra homogenate in appropriate BioHazard receptacle 
b. Call for pick-up if has been more than 1 week or the last sample.  
i. Environmental Health and Safety -> Medical Waste ->  
ii. 532-5856 
5. In additional step, core approximately .2-.25 g fecal homogenate 
a. Bore maybe made modifying a 1-3 mL syringe and validating for weight. 
b. In a 1 mL syringe, approximately .2 mL mark is appropriate.  
i. Fisherbrand - Sterile; Luer Lok; 1.0 mL Centered tip 
ii. Catolog # - 14-823-261 – 1000 – 342.62 
6. Place core into 3 cryocontainers. 
a. Cryovials 
i. Fisherbrand – Cryogenic Vial – 2 mL, sterile 
ii. FisherBrand Cat. # - 10-500-26 
iii. *Note these are for extra* 
OR 
b. Micro Tube 2 mL 
i. Sarstedt – Micro tube 2 mL –  
ii. Ref # 72.694.006 – 100 pc 
7. Fill an addition 15 mL Cryogenic Vial with stool 
a. Extra storage if necessary 
b. ThermoScientific – Nalgene – 15 mL Cryogenic Specimen Vial 
c. Screw Close – Cat # 5005-0015 
8. Use a sterile knife to complete the transfer 
a. Sterileware – Bel-Art Products – Sampling Knife  
b. Cat # - 369650000 – 286.20 Box of 200 
c. Can be a sterile knife to reduce introduction of outside DNA 
d. However, I don’t see a problem with simple sterilization of the same knife. 
9. Place all samples in -20oF while preparing multiple samples.   
Transfer to the -80
o
F as soon as all samples are completed. 
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 DNA Extraction Prep 
(References to reference for fecal samples include Nechvatal et al, 2008; Martinez et al., 2010) 
1) Samples will be thawed only prior to use 
a. Samples will be thawed in 32-37oF conditions 
b. Minimizing freeze thaw is important for DNA integrity and should be avoided 
c. TE buffer is appropriate in our case PBS, perhaps other buffers are appropriate 
too.  
2) Samples should be recovered by centrifugation  
a. 8,000 x g for 5 min 
b. Remove supernatant until 0.5ml remains 
c. Mix with pipette using sterile cut-off tip 
i. Mix approximately 15 times 
ii. Keep each sample mixed and treated identically 
iii. Switch tips between all samples 
iv. Transfer into MoBIO Bead Beating Tubes 
3) Follow Procedures as in MoBio kit 
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 MoBio Procedure – PowerSoil Kit 
 
1) Add .25 g of fecal sample from recollection to provided PowerBead Tubes 
a. 0.50 g worked better for me 
b. This tube contains a buffer that will help disperse particles  
c. Begin to dissolve fecal acids 
d. Protect nucleic acids from degradation 
2) Gently vortex 
a. Only enough to disperse the solution 
3) Add solution C1  
a. If C1 is precipitated heat to 60oC, this will dissolve 
b. Contains SDS and other agents to help disrupt and lyse cells. 
c. SDS is anionic which disrupts FA, especially of cell membrane 
d. Can be used while warm 
4) Add 60 µl of Solution C1 and invert several times (vortex briefly will also do) 
5) Secure power bead tubes securely to Vortex Adapter.  
6) Vortex for 10 minutes 
a. This completes homogenization and lysis. 
7) Place Power Bead Tubes in the centrifuge @ 10,000 x g for 30 seconds at room temp.   
a. Tubes may break if 10,000 x g is surpassed 
8) Transfer supernatant to clean 2 mL Collection Tube 
a. Should have approximately ½ mL of supernatant at this step.  
b. May be dark solution which is fine.  Subsequent steps will help with any carry 
over. 
9) Add 250 µL of Solution C2 and vortex for 5 seconds 
10) Incubate for 5 min @ 5°C. 
a. IRT or inhibitor removal technology, removes PCR inhibitors. 
b. Precipitates non-DNA organic and inorganic material including extraneous 
substances, cell debris, proteins.  
11) Centrifuge the tubes at room temp for 1 min at 10,000 x g 
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12) Being careful to avoid the pellet, transfer up to 600 µL of supernatant to a clean 2 mL 
Collection Tube 
13) Add 200 µL of Solution C3 and vortex briefly.  Incubate at 4°C for 5 min. 
a. Another IRT 
14) Centrifuge at room temp for 1 min at 10,000 x g 
15) Transfer up to 750 µL of supernatant to a clean 2 mL Collection Tube 
16) Shake to mix Solution C4 
17) Add 1.2 mL of Solution C4 to the supernatant, vortex for 5 sec 
a. BE CAREFUL not to exceed the RIM of the tube 
18) Load approximately 675 µL onto a Spin Filter and centrifuge at 10,000 x g for 1 min 
19) Discard the flow through and add an addition 675 µL to the Spin Filter and cent for 
10,000 x g for 10 min. 
20) Load remaining supernatant and essentially repeat.   
a. DNA is selectively binding to the silica membrane in the filter.  C 
b. Contaminants pass through leaving only the DNA 
21) Add 500 µL of Solution C5 and centrifuge at room temp for 30 sec at 10,000 x g.  
a. Ethanol based wash solution to further clean the DNA passing contaminants 
through 
22) Discard the Flow Through from the 2 mL collection tube. 
23) Centrifuge for 1 min at 10,000 x g 
a. Removes all traces of wash 
24) Carefully place Spin Filter in clean 2 mL Collection Tube 
a. Be extra careful to avoid splashing of flow through C5 ethanol solution 
25) Add 100 µL of Solution C6 to the center of the white filter membrane 
a. Sterile elution buffer (10mM TRIS) 
b. Wet the entire membrane 
c. Sterile DNAase and DNA free PCR grade water may be used to elute 
26) Centrifuge for 30 sec @ 10,000 x g. 
27) Discard the Spin Filter 
28) DNA tube is ready for Downstream application 
29) DNA can be stored at -20 or -80°C until further use. 
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 DNA Quantification and Quality Estimate 
 
1) Nanodrop will be the necessary equipment use for this procedure.   
a. Nanodrop – Thermo Scientific – UV-VIS – Wilmington, DE 
b. Need to determine the specific instrument 
2) Ensure the computer and Nanodrop on are set to “on” 
3) Wash the NanoDrop pedestal 
4) Lift the arm and remove the previous wipe (should be present) 
5) Add 4-5 µL of purified water to the lower pedestal, then lower the arm 
6) Wait 30-60 secs 
7) Lift the pedestal arm and use the wipe to vigorously scrub both the upper and lower 
pedestals 
a. This seems excessive?  
8) Open NanoDrop software 
9) Initialize 
10) Click “Nucleic Acid” button in the NanoDrop software. 
11) DO NOT click okay until you’ve added water 
12) Add 2 µL of purified water to the lower pedestal and lower upper arm. 
13) Click “Okay,” on the omputer and wait ~20 sec while the NanoDrop initializes 
14) When it’s done, lift the upper arm and dry pedestal with a wipe 
15) Blank the Nanodrop 
16) Add 2µL of the buffer from your sample.  Whatever the suspension is. 
17) Lower the upper arm of the NanoDrop and click “Blank”  
18) Wait ~20 sec for the blank measurement to be made. 
19) When it’s done, life the upper arm and dry the pedestal with a wipe. 
20) Measure your sample 
21) Add 2 µL of your sample to the lower pedestal, then lower the upper arm 
22) In the Sample ID box, type in the name of your sample. 
23) Click the “Measure” button on the software and wait ~20 sec.   
24) Lift upper arm when complete, dry the pedestal 
a. Portions of your samples may be retained if you wish. 
25) Collect Data 
26) Write down all measurements interested in 
27) Click “Print Screen” if interested in the complete spectrum 
28) Click “Print Report” to get a table of all the data.  
29) Clean the Pedestal 
30) Add 4-5 µL of purified water to the lower pedestal and lower arm 
31) Wait 30-60 second and scrub. 
32) Place a new folded lab wipe on the lower pedestal and close the upper arm 
33) Shutdown 
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 Standardizing DNA Concentration 
 
This entails individually adjusted concentrations of all samples to 5 or 10 ng/µL  
Helps reduced bias in the steps moving forward. 
 
Dilution should be commensurate with total PCR volume extracted, i.e. a protocol with 25 µL or 
50 µL.   
 
Protocol for August 27
th
 Prep.   
 
1. Samples were adjusted to equal 10 ng/µL final concentration.   
2. This was calculated based on the follow procedure.  
3. Observed Quantity / Amount to be achieved = Dilution Factor (DF) 
4. All values were calculated from 100 µL observed sample. 
5. Thus the DF X 100 µL = Final Volume 
6. Final volume – 100 µL =Dilution Volume 
a. All working solutions are differing amount 
b. But using 100 µL for ease of calculation this is best. 
c. If the extract does not allow for 100 µL, the adjust as necessary 
d. The same steps still apply, just choose a consistent DF 
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 Preform PCR Reactions 
 
1. PCR reactions are performed first by creating a 96 well template to keep samples 
organized.   
a. Excel is easiest 
2. Sterile nuclease free PCR tubes are place in the appropriate location. 
3. In one tube be sure to provide a negative control 
4. A positive control is not as necessary as, no bands are no bands. 
5. The following are for 50 µL RXN 
a. COMPLETE ON ICE, ALWAYS ADD MM last 
b. 25 µL of Master Mix (AmpliTaq Gold 360 Master Mix, Applied BioSystems, 
Life Technologies, Carlsbad, CA) 
c. 5 µL template (10 ng/ µL) 
d. 5 µL primer forward (IDT) FC9F-GAGTTTGATCCTTGGCTCAG 
e. 5 µL primer reverse (IDT) FC541R-TTACCGCGGCTGCTGG 
f. 10 µL NCF H2O 
6. Basic Procedure (August 27th, 2012 protocol was Shawn’s) 
a. Basically, Denaturing Step 95°C 8 min  
b. Cycle Denaturing 95°C for 30 seconds 
c. Annealing 54°C for 1 min 
d. Extension 72°C for 2 min 
e. Repeat 24 cycles (25 cycles total, as you will enter cycle and have to repeat) 
f. Final Elongation at 72°C for 10 min  
Repeat technical replicates 2 and 3 after one complete run and gel. 
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 Run Gels for PCR Products 
 
1. Prepare Gel about 1 hour before use (When starting the thermocylcer) 
a. A gel can last covered in fridge overnight at most.  
b. Gel for a mini = .45 g agarose, 3 mL 10x TBE (Tris-Boric Acid-EDTA), 27 mL 
of Distilled water 
c. Our mix for the 27th, 2012 was .45 g agarose, 6 mL 5x TBE, and 24 mL of 
distilled water 
d. Remove well Die slowly and consistently to prevent ripping the gel.   
e. Prepare Electrophloretic box, black goes to black and red to red electrodes.   
f. Wells should run from Black to Red or Pos to Neg.  
i. RUN TO THE RED 
g. Run 110 V for 1 hr, with approximately 60 mAmps, if mAmps are 40 or less wash 
solution may need to be replaced.  
h. Wash Solution is 1x TBE (Usually re-used 5-6 times, then replaced.)  
i. Fill wash solution about 1 cm over the gel   
2. To load sample, tape the four sides of a parafilm to the lab bench. 
3. Place 2 µL of Loading dye as a dot on the parafilm 
a. Our Loading dye is 6X, so we dilute 2 to 10 µL 
b. I suppose a 1 to 5 is also a reasonable preposition.  
4. Place a “dot” for every sample to be analyzed include the ladder. 
a. The ladder includes 100, 200, 300, 500, 750, 1000 bp, I believe 
5. 10 µL of sample and ladder will be added to each dot.  
6. Be careful to have samples, properly labeled, to keep straight.  
7. Load the sample into the loading wells.   
a. Be careful, some do this before the wash solution is added.  
b. I did with the solution in and it worked fine.  
c. I place the pipette tip in the well and  
8. After 1 hr cycle, stop machine 
9. Pour TBE back into container.   
10. Wash for 10 min Ethidium Bromide. 
a. Fill EtBr enough to cover the gel.    
b. Must use lab-coat and gloves always for EtBr.   
c. Must not touch anything other than designated material once glove contaminated 
with EtBr (Very suspected human carcinogen) 
11. Place on stir plate gently for 10 min for large gels, 5 for small.  
a. Never use gloved hand to turn on stir plate as could contaminate with EtBr 
12. Dispose of EtBr into storage container.   
13. Wash with water, repeat stir plate for10 or 5 respectively, depending on sample.  
14. Dump water down drain using funnel (Also, use the designated spatula to hold the gel 
together and not dump out.) 
15. Wash with water and place on stir plate same as above. 
16. Once washed and drain take to lab 322 – Carol Ferguson’s lab to use camera (Co-owned 
by Ari). 
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17. Plan to remove gloves and take extra and be sure to not wear gloved hands to touch 
places in hallways!!!!!!!!!  Prepare for necessary clean-up and contact if dropped or an 
accident were to happen!!!! 
18. Open Camera Shortcut 
19. Open camera door, turn on fluorescent light,  
20. Remove Tray 
21. Place Wells towards the left on the plastic tray, with wing sides of tray facing up. 
22. Place in camera 
23. Turn off fluorescent light 
24. Close door and turn on UV light 
25. Adjust settings to see the bands.   
26. Integration was  used in our case (however, the user was not ultimately sure what the 
integration was doing) 
27. Take picture, store, and verify the presence of the bp appropriate for your amplicon 
28. Remove gel and place in same container brought down. 
29. Remove one glove throw all wastes in with gel and container, to dispose in Ari’s lab.  
Plus this leaves an open hand for hallway interaction.  Don’t carry this during busy 
periods. 
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 Secondary PCR products 
1. BASIC PREP 
a. Sterile nuclease free PCR tubes are place in the appropriate location. 
b. In one tube be sure to provide a negative control 
c. Here a TEMPLATE IS A MUST 
d. EACH sample will have its own unique barcode.   
e. A positive control is not as necessary as, no bands are no bands. 
 
2. BARCODE PRIMERS 
a. Refer to following page for complete list 
b. Example of decoding the below 
c.  
30 - Base Pair Adapter/Linker 
10 - Tag - Barcode - 
MID Primer 
CCATCTCATCCCTGCGTGTCTCCGACTCAG ACGAGTGCGT WTTACCGCGGCTGCTGG 
 
d. The adapter/linker followed by the barcode (unique 10 digit code) the primer 
excluding the “W”. 
e.  
 
 
3. PCR REACTION PREP 
4. The following are for 50 µL RXN 
a. COMPLETE ON ICE, ALWAYS ADD MM last 
b. 25 µL of Master Mix (AmpliTaq Gold 360 Master Mix, Applied BioSystems,Life 
Technologies, Carlsbad, CA) 
c. 5 µL template (10 ng/ µL) 
d. 5 µL primer forward (IDT) FC9F-GAGTTTGATCCTTGGCTCAG 
i. Here an A adapter is added for pyrosequencing identification 
e. 5 µL primer reverse (IDT) FC541R-TTACCGCGGCTGCTGG 
i. Here the B adapter is added to the R primer as this will be the sequencing 
direction in the 454 
f. 10 µL NCF H2O 
 
Basic Procedure  
5. Basically, Denaturing Step 95°C 8 min  
6. Cycle Denaturing 95°C for 30 seconds 
7. Annealing 54°C for 1 min 
8. Extension 72°C for 2 min 
9. Repeat 4 cycles  
10. Final Elongation at 72°C for 10 min  
11. Repeat technical replicates 2 and 3 after one complete run and gel. 
a. Gels always ensure a product has run. 
b. In this case we are interested in the “jump-up” 
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c. Here the secondary products should show up about 50 bp longer 
d. These are the extra for the Barcodes and Adapters, we assume it worked.  
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 Reverse Primer Barcode and 454 Adapters 
Plate Name:
Well Position Sequence Name
1 A1 A-FC-541R-A1 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGAGTGCGTWTTACCGCGGCTGCTGG
2 B1 A-FC-541R-B1 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGCTCGACAWTTACCGCGGCTGCTGG
3 C1 A-FC-541R-C1 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGACGCACTCWTTACCGCGGCTGCTGG
4 D1 A-FC-541R-D1 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGCACTGTAGWTTACCGCGGCTGCTGG
5 E1 A-FC-541R-E1 CCATCTCATCCCTGCGTGTCTCCGACTCAGATCAGACACGWTTACCGCGGCTGCTGG
6 F1 A-FC-541R-F1 CCATCTCATCCCTGCGTGTCTCCGACTCAGATATCGCGAGWTTACCGCGGCTGCTGG
7 G1 A-FC-541R-G1 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTGTCTCTAWTTACCGCGGCTGCTGG
8 H1 A-FC-541R-H1 CCATCTCATCCCTGCGTGTCTCCGACTCAGCTCGCGTGTCWTTACCGCGGCTGCTGG
9 A2 A-FC-541R-A2 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCTCTATGCGWTTACCGCGGCTGCTGG
10 B2 A-FC-541R-B2 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGATACGTCTWTTACCGCGGCTGCTGG
11 C2 A-FC-541R-C2 CCATCTCATCCCTGCGTGTCTCCGACTCAGCATAGTAGTGWTTACCGCGGCTGCTGG
12 D2 A-FC-541R-D2 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGAGAGATACWTTACCGCGGCTGCTGG
13 E2 A-FC-541R-E2 CCATCTCATCCCTGCGTGTCTCCGACTCAGATACGACGTAWTTACCGCGGCTGCTGG
14 F2 A-FC-541R-F2 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCACGTACTAWTTACCGCGGCTGCTGG
15 G2 A-FC-541R-G2 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTCTAGTACWTTACCGCGGCTGCTGG
16 H2 A-FC-541R-H2 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCTACGTAGCWTTACCGCGGCTGCTGG
17 A3 A-FC-541R-A3 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGTACTACTCWTTACCGCGGCTGCTGG
18 B3 A-FC-541R-B3 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGACTACAGWTTACCGCGGCTGCTGG
19 C3 A-FC-541R-C3 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTAGACTAGWTTACCGCGGCTGCTGG
20 D3 A-FC-541R-D3 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACGAGTATGWTTACCGCGGCTGCTGG
21 E3 A-FC-541R-E3 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACTCTCGTGWTTACCGCGGCTGCTGG
22 F3 A-FC-541R-F3 CCATCTCATCCCTGCGTGTCTCCGACTCAGTAGAGACGAGWTTACCGCGGCTGCTGG
23 G3 A-FC-541R-G3 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCGTCGCTCGWTTACCGCGGCTGCTGG
24 H3 A-FC-541R-H3 CCATCTCATCCCTGCGTGTCTCCGACTCAGACATACGCGTWTTACCGCGGCTGCTGG
25 A4 A-FC-541R-A4 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGCGAGTATWTTACCGCGGCTGCTGG
26 B4 A-FC-541R-B4 CCATCTCATCCCTGCGTGTCTCCGACTCAGACTACTATGTWTTACCGCGGCTGCTGG
27 C4 A-FC-541R-C4 CCATCTCATCCCTGCGTGTCTCCGACTCAGACTGTACAGTWTTACCGCGGCTGCTGG
28 D4 A-FC-541R-D4 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGACTATACTWTTACCGCGGCTGCTGG
29 E4 A-FC-541R-E4 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGCGTCGTCTWTTACCGCGGCTGCTGG
30 F4 A-FC-541R-F4 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTACGCTATWTTACCGCGGCTGCTGG
31 G4 A-FC-541R-G4 CCATCTCATCCCTGCGTGTCTCCGACTCAGATAGAGTACTWTTACCGCGGCTGCTGG
32 H4 A-FC-541R-H4 CCATCTCATCCCTGCGTGTCTCCGACTCAGCACGCTACGTWTTACCGCGGCTGCTGG
33 A5 A-FC-541R-A5 CCATCTCATCCCTGCGTGTCTCCGACTCAGCAGTAGACGTWTTACCGCGGCTGCTGG
34 B5 A-FC-541R-B5 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGACGTGACTWTTACCGCGGCTGCTGG
35 C5 A-FC-541R-C5 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACACACACTWTTACCGCGGCTGCTGG
36 D5 A-FC-541R-D5 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACACGTGATWTTACCGCGGCTGCTGG
37 E5 A-FC-541R-E5 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACAGATCGTWTTACCGCGGCTGCTGG
38 F5 A-FC-541R-F5 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACGCTGTCTWTTACCGCGGCTGCTGG
39 G5 A-FC-541R-G5 CCATCTCATCCCTGCGTGTCTCCGACTCAGTAGTGTAGATWTTACCGCGGCTGCTGG
40 H5 A-FC-541R-H5 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCGATCACGTWTTACCGCGGCTGCTGG
41 A6 A-FC-541R-A6 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCGCACTAGTWTTACCGCGGCTGCTGG
42 B6 A-FC-541R-B6 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCTAGCGACTWTTACCGCGGCTGCTGG
43 C6 A-FC-541R-C6 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCTATACTATWTTACCGCGGCTGCTGG
44 D6 A-FC-541R-D6 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGACGTATGTWTTACCGCGGCTGCTGG
45 E6 A-FC-541R-E6 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGTGAGTAGTWTTACCGCGGCTGCTGG
46 F6 A-FC-541R-F6 CCATCTCATCCCTGCGTGTCTCCGACTCAGACAGTATATAWTTACCGCGGCTGCTGG
47 G6 A-FC-541R-G6 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGCGATCGAWTTACCGCGGCTGCTGG
48 H6 A-FC-541R-H6 CCATCTCATCCCTGCGTGTCTCCGACTCAGACTAGCAGTAWTTACCGCGGCTGCTGG
49 A7 A-FC-541R-A7 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGCTCACGTAWTTACCGCGGCTGCTGG
50 B7 A-FC-541R-B7 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTATACATAWTTACCGCGGCTGCTGG
51 C7 A-FC-541R-C7 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTCGAGAGAWTTACCGCGGCTGCTGG
52 D7 A-FC-541R-D7 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTGCTACGAWTTACCGCGGCTGCTGG
53 E7 A-FC-541R-E7 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGATCGTATAWTTACCGCGGCTGCTGG
54 F7 A-FC-541R-F7 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGCAGTACGAWTTACCGCGGCTGCTGG
55 G7 A-FC-541R-G7 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGCGTATACAWTTACCGCGGCTGCTGG
56 H7 A-FC-541R-H7 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTACAGTCAWTTACCGCGGCTGCTGG
57 A8 A-FC-541R-A8 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTACTCAGAWTTACCGCGGCTGCTGG
58 B8 A-FC-541R-B8 CCATCTCATCCCTGCGTGTCTCCGACTCAGCTACGCTCTAWTTACCGCGGCTGCTGG
59 C8 A-FC-541R-C8 CCATCTCATCCCTGCGTGTCTCCGACTCAGCTATAGCGTAWTTACCGCGGCTGCTGG
60 D8 A-FC-541R-D8 CCATCTCATCCCTGCGTGTCTCCGACTCAGTACGTCATCAWTTACCGCGGCTGCTGG
61 E8 A-FC-541R-E8 CCATCTCATCCCTGCGTGTCTCCGACTCAGTAGTCGCATAWTTACCGCGGCTGCTGG
62 F8 A-FC-541R-F8 CCATCTCATCCCTGCGTGTCTCCGACTCAGTATATATACAWTTACCGCGGCTGCTGG
63 G8 A-FC-541R-G8 CCATCTCATCCCTGCGTGTCTCCGACTCAGTATGCTAGTAWTTACCGCGGCTGCTGG
64 H8 A-FC-541R-H8 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCACGCGAGAWTTACCGCGGCTGCTGG
65 A9 A-FC-541R-A9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCGATAGTGAWTTACCGCGGCTGCTGG
66 B9 A-FC-541R-B9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCGCTGCGTAWTTACCGCGGCTGCTGG
67 C9 A-FC-541R-C9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTCTGACGTCAWTTACCGCGGCTGCTGG
68 D9 A-FC-541R-D9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGAGTCAGTAWTTACCGCGGCTGCTGG
69 E9 A-FC-541R-E9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGTAGTGTGAWTTACCGCGGCTGCTGG
70 F9 A-FC-541R-F9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGTCACACGAWTTACCGCGGCTGCTGG
71 G9 A-FC-541R-G9 CCATCTCATCCCTGCGTGTCTCCGACTCAGTGTCGTCGCAWTTACCGCGGCTGCTGG
72 H9 A-FC-541R-H9 CCATCTCATCCCTGCGTGTCTCCGACTCAGACACATACGCWTTACCGCGGCTGCTGG
73 A10 A-FC-541R-A10 CCATCTCATCCCTGCGTGTCTCCGACTCAGACAGTCGTGCWTTACCGCGGCTGCTGG
74 B10 A-FC-541R-B10 CCATCTCATCCCTGCGTGTCTCCGACTCAGACATGACGACWTTACCGCGGCTGCTGG
75 C10 A-FC-541R-C10 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGACAGCTCWTTACCGCGGCTGCTGG
76 D10 A-FC-541R-D10 CCATCTCATCCCTGCGTGTCTCCGACTCAGACGTCTCATCWTTACCGCGGCTGCTGG
77 E10 A-FC-541R-E10 CCATCTCATCCCTGCGTGTCTCCGACTCAGACTCATCTACWTTACCGCGGCTGCTGG
78 F10 A-FC-541R-F10 CCATCTCATCCCTGCGTGTCTCCGACTCAGACTCGCGCACWTTACCGCGGCTGCTGG
79 G10 A-FC-541R-G10 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGAGCGTCACWTTACCGCGGCTGCTGG
80 H10 A-FC-541R-H10 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGCGACTAGCWTTACCGCGGCTGCTGG
81 A11 A-FC-541R-A11 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTAGTGATCWTTACCGCGGCTGCTGG
82 B11 A-FC-541R-B11 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTGACACACWTTACCGCGGCTGCTGG
83 C11 A-FC-541R-C11 CCATCTCATCCCTGCGTGTCTCCGACTCAGAGTGTATGTCWTTACCGCGGCTGCTGG
84 D11 A-FC-541R-D11 CCATCTCATCCCTGCGTGTCTCCGACTCAGATAGATAGACWTTACCGCGGCTGCTGG
85 E11 A-FC-541R-E11 CCATCTCATCCCTGCGTGTCTCCGACTCAGATATAGTCGCWTTACCGCGGCTGCTGG
86 F11 A-FC-541R-F11 CCATCTCATCCCTGCGTGTCTCCGACTCAGATCTACTGACWTTACCGCGGCTGCTGG
87 G11 A-FC-541R-G11 CCATCTCATCCCTGCGTGTCTCCGACTCAGCACGTAGATCWTTACCGCGGCTGCTGG
88 H11 A-FC-541R-H11 CCATCTCATCCCTGCGTGTCTCCGACTCAGCACGTGTCGCWTTACCGCGGCTGCTGG
89 A12 A-FC-541R-A12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCATACTCTACWTTACCGCGGCTGCTGG
90 B12 A-FC-541R-B12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGACACTATCWTTACCGCGGCTGCTGG
91 C12 A-FC-541R-C12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGAGACGCGCWTTACCGCGGCTGCTGG
92 D12 A-FC-541R-D12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTATGCGACWTTACCGCGGCTGCTGG
93 E12 A-FC-541R-E12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCGTCGATCTCWTTACCGCGGCTGCTGG
94 F12 A-FC-541R-F12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCTACGACTGCWTTACCGCGGCTGCTGG
95 G12 A-FC-541R-G12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCTAGTCACTCWTTACCGCGGCTGCTGG
96 H12 A-FC-541R-H12 CCATCTCATCCCTGCGTGTCTCCGACTCAGCTCTACGCTCWTTACCGCGGCTGCTGG
Sequence
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Amplicon Cleaning 
 
1. Clean with AMPure per instructions 
Procedure 96 Well Format: 
2. Determine whether or not a plate transfer is necessary 
a. If the PCR reaction volume * 2.8 exceeds the volume of the PCR plate, a transfer 
to a 300 μL round bottom plate is required. Agencourt recommends the Costar 
3795 plate to work with the Agencourt AMPure kit, because the Agencourt 
SPRIPlate96R was designed specifically for the Costar plate. The PCR Reactions 
can be set up in polypropylene PCR/ thermal cycling plates. The cleanup reaction 
can be performed in the same plate, if the volume of the PCR reaction is below 71 
μL. A 300 μl plate will hold up to 105 μL of sample and 189 μL of Agencourt 
AMPure. 
3. Gently shake the Agencourt AMPure bottle to resuspend any magnetic particles 
that may have settled. Add Agencourt AMPure according to PCR reaction volume 
chart below: 
PCR Reaction Volume (μL) Agencourt AMPure Volume (μL) 
 
5 9 
7 12.6 
10 18 
14 25 
 
The volume of Agencourt AMPure for a given reaction can be derived from the following 
equation: (Volume of Agencourt AMPure per reaction) = 1.8 x (Reaction Volume) 
 
 
 
 
 
4. Mix the Agencourt AMPure and PCR reaction thoroughly by pipette mixing 10 
times or vortexing for 30 seconds. 
a. This step binds PCR products 100bp and larger to the magnetic beads. Pipette 
mixing is preferable as it tends to be more reproducible. If vortexing is used, it is 
recommended to seal the plate with a plate seal before vortexing. The color of the 
mixture should appear homogenous after mixing. Let the mixed samples incubate 
for 3 -5 minutes at room temperature for maximum recovery (optional). This is 
strongly recommended for reactions 50 μl and larger. 
5. Place the reaction plate onto an Agencourt SPRIPlate 96R for 5 - 10 minutes to 
separate beads from solution. 
a. The separation time is dependent on the size of the reaction. Wait for the solution 
to clear before proceeding to the next step. 
6.  Aspirate the cleared solution from the reaction plate and discard. 
b. This step must be performed while the reaction plate is situated on the Agencourt 
SPRIPlate 96R. Do not disturb the ring of separated magnetic beads. 
Due to the total volume of PCR reaction plus Agencourt AMPure, it is not 
possible to purify PCR reactions larger than 14 μL within the well of 384 well 
plates (14 μL reaction + 25 μL Agencourt AMPure = 39 μL). 
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7.  Dispense 200 μL of 70% ethanol to each well of the reaction plate and incubate for 
30 seconds at room temperature. Aspirate out the ethanol and discard. Repeat for a 
total of two washes. 
c. See Note below for removal amendment.  
d. It is important to perform these steps with the reaction plate situated on an 
Agencourt SPRIPlate 96R. Do not disturb the separated magnetic beads. Be sure 
to remove all of the ethanol from the bottom of the well as it may contain residual 
contaminants. The ethanol can also be discarded by inverting the plate to decant, 
but this must be done while the plate is situated on the Agencourt SPRIPlate 96R. 
8.  Place the reaction plate on bench top to air-dry. Be sure to allow the plate to dry 
completely. 
e. The plate should be left to air-dry for 10-20 minutes on a bench top to allow 
complete evaporation of residual ethanol. Longer drying times may be required 
for microarraying.  Alternatively the plate can be incubated at 37°C for faster 
evaporation. If the samples will be used immediately, proceed to Step 8 for 
elution. If the samples will not be used immediately, the dried plate may be sealed 
and stored at 4°C or -20°C. 
9. Add 40 μL of elution buffer (TRIS-Acetate, DiH2O, or TE) to each well of the 
reaction plate and seal to vortex 30 seconds or pipette mix 10 times.   
a.  The liquid level will be high enough to contact the magnetic beads at a 40 μl 
elution volume. A greater volume of elution buffer can be used, but using less than 
40 μL will require extra vortexing (to ensure the liquid comes into contact with the 
beads) and may not be sufficient to fully elute all of the product. 10 mM Tris-
Acetate pH 8.0 (recommended), reagent grade water, or TE buffer may be used for 
the elution. Recommended elution conditions are sealing and vortexing or 30 
seconds or 10 pipette mixes. Elution is quite rapid and it is not necessary for the 
beads to go back into solution for complete elution to occur.  When setting up  
ownstream reactions, pipette the DNA from the plate while it is situated on the 
Agencourt SPRIPlate96R. This will prevent bead carry over (however, the beads 
do not inhibit thermal cycling reactions). For long term freezer storage, Agencourt 
recommends transferring Agencourt AMPure purified samples into a new plate 
away from the magnetic particles. 
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*Note, when removing the alcohol wash, clamp tight to the 96 well plate, be sure to keep 
pressure between the magnet plate and your template plate.  Then simply throw the water out.  
The final step you lightly slam the plate on paper towels.  Very nerve-wrecking, but very quick 
and efficient.  
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BioAnalyze 
 
1. Sample were analyzed in Agilent BioAnalyzer2100 
2. Using the DNA 1000 Kits 
3. Samples were analyzed in 123 Coles @ Vetmed in the COBRE center 
a. Contact was Donald Harbinger – COBRE manager 
Follow manufacturer instructions following the plate instructions. 
Agilent DNA 1000 Assay Protocol - Edition April 2007 
Handling DMSO 
Kit components contain DMSO. Because the dye binds to nucleic acids, it should be 
treated as a potential mutagen and used with appropriate care.  Wear hand and eye 
protection and follow good laboratory practices when preparing and handling reagents 
and samples. Handle the DMSO stock solutions with particular caution as DMSO is 
known to facilitate the entry of organic molecules into tissues. 
Preparing the Gel-Dye Mix 
1 Allow DNA dye concentrate (blue �) and DNA gel matrix (red �) to equilibrate to 
room temperature for 30 min. 
2 Vortex DNA dye concentrate (blue �) and add 25 μl of the dye to a DNA gel matrix 
vial (red �). 
3 Vortex solution well and spin down. Transfer to spin filter. 
4 Centrifuge at 2240 g ± 20 % for 15 min. Protect solution from light. Store at 4 °C. 
Loading the Gel-Dye Mix 
1 Allow the gel-dye mix equilibrate to room temperature for 30 min before use. 
2 Put a new DNA chip on the chip priming station. 
3 Pipette 9.0 μl of gel-dye mix in the well marked . 
4 Make sure that the plunger is positioned at 1 ml and then close the 
chip priming station. 
5 Press plunger until it is held by the clip. 
6 Wait for exactly 60 s then release clip. 
7 Wait for 5 s. Slowly pull back plunger to 1ml position. 
8 Open the chip priming station and pipette 9.0 μl of gel-dye mix in the wells marked . 
Loading the Markers 
1 Pipette 5 μl of marker (green �) in all 12 sample wells and ladder well. Do not leave 
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any wells empty. 
Loading the Ladder and the Samples 
1 Pipette 1 μl of DNA ladder (yellow �) in the well marked . 
2 In each of the 12 sample wells pipette 1 μl of sample (used wells) or 1 μl of de-ionized 
water (unused wells). 
3 Put the chip horizontally in the adapter and vortex for 1 min at the indicated setting 
(2400 rpm). 
4 Run the chip in the Agilent 2100 bioanalyzer within 5 min. 
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 Microbial Sequencing 
 
1. Samples will be prepared and Sequenced in the Integrated Genomics Facility 
a. Alina Akhunova is the contact  
2. At the IGL samples will be go throw emPCR and then sequenced with Next-generation 
sequencing or 454, which is a high-throughput sequencing.  Sequencing by synthesis with 
all sequences elongated in parallel allows the technology to produce 1.2 million reads per 
chip.  In our case approximately 300,000 reads or a ¼ reaction.  
s in alphabetical order (A, B, C, etc.). 
